<rss version='2.0'>

                    <channel>

                    <title><![CDATA[Gastric Cancer]]></title>

                    <link>https://www.benthamscience.com</link>

                    <description>

                    RSS Feed for Disease Wise Article | BenthamScience

                    </description>

                    <generator>EurekaSelect (+http://eurekaselect.com)</generator>

                    <pubDate>Mon, 16 Mar 2026 02:52:23 +0000</pubDate>

                    <image>

                    <title><![CDATA[Gastric Cancer]]></title>

                    <url>https://www.benthamscience.com</url>

                    <link>https://www.benthamscience.com</link>

                    </image><item><title><![CDATA[Preface]]></title><link>https://www.benthamscience.comchapter/23582</link><description><![CDATA[]]></description> </item><item><title><![CDATA[Status of <i>Helicobacter</i> pylori in Gut Microbiome and Precision Medicine]]></title><link>https://www.benthamscience.comchapter/22445</link><description><![CDATA[<i>Helicobacter</i> pylori (<i>H. pylori</i>) is a Gram-negative, slow-growing microaerobic bacterium that infects over 50% of the global population. Around 58,000 years ago, <i>H. pylori</i> and humans co-evolved and migrated from East Africa, the original birthplace of Homo sapiens. Its distinct characteristics, such as urease, helical structure, and motile flagella, allow it to survive in the human stomach under stressful conditions. The occurrence of <i>H. pylor</i>i in the stomach can be beneficial or detrimental to human health, depending on the host's genetic vulnerability, immunity, and environmental factors. Although most of the <i>H. pylori</i>-infected patients are asymptomatic, about 20% develop stomach illnesses such as peptic ulcer (10-15%), gastric adenocarcinoma (1-3%), and mucosa-associated lymphoid tissue (MALT) lymphoma that is common to aged people. People who do not have <i>H. pylori</i> infection, on the other hand, are predisposed to a variety of diseases, including gastric esophageal disease (GERD), oesophageal cancer, diabetes mellitus, and asthma. Clinical symptoms in infected patients vary significantly geographically due to the high level of genetic variation in the bacterial genome and the presence of numerous virulence factors. The entire sickness is treated by eradicating <i>H. pylori</i> with antibiotics and proton pump inhibitors. However, the rise in antibiotic resistance and a lack of effective vaccinations make it tough to combat the infection. This chapter aims to shed light on host-pathogen interactions by analysing the bacterium's persistence and pathogenesis in the context of human health and precision medicine.&nbsp;<br>]]></description> </item><item><title><![CDATA[Preface]]></title><link>https://www.benthamscience.comchapter/22437</link><description><![CDATA[]]></description> </item><item><title><![CDATA[Coumarins and Their Derivatives as Anti-Inflammatory Agents]]></title><link>https://www.benthamscience.comchapter/22378</link><description><![CDATA[Coumarins are a diverse class of phytochemicals found in many human diets and have been shown to have various pharmacological actions. The chapter discusses the role of coumarins in disease prevention and treatment and their classification based on structure. It also highlights that the various schemes of coumarin possess antiinflammatory properties, making them a promising scaffold for the synthesis of a new class of anti-inflammatory drugs. Overall, this chapter provides valuable information on the potential use of coumarins as anti-inflammatory agents and their synthetic aspects. This book chapter focuses on the development of various possible potential anti-inflammatory molecules having a coumarin core.&nbsp;<br>]]></description> </item><item><title><![CDATA[Anti-Obesity Potential of Seaweeds]]></title><link>https://www.benthamscience.comchapter/22346</link><description><![CDATA[<i></i>An excessive buildup of body fat is a sign of the metabolic disease known as obesity. The primary etiological factor for obesity is thought to be an imbalance between energy intake and expenditure, where genetic factors can also play a significant role. The rise in obesity rates over the past few years has encouraged a focus on adipose tissue biology and the precise processes behind adipocyte differentiation and adipogenesis. Due to the advent of several <i>in vitro</i> cell models and molecular biology tools, adipocyte commitment and differentiation have become complicated processes that may be studied to gain a better knowledge of adipogenesis and adipocyte malfunction related to obesity. As the available anti-obesity drugs and surgical interventions cause adverse effects, it is important to rely on natural-based therapeutics in order to manage obesity and its associated complications. Seaweeds are a rich source of natural bioactive compounds that exhibit human beneficial effects. Fucoxanthin, phlorotannins, fucoidan, and alginate are some of the bioactive compounds present in seaweeds exhibiting anti-obesity potential mainly <i>via</i> the inhibition of digestive enzymes and adipocyte differentiation. Therefore, this chapter mainly focuses on the anti-obesity potential of seaweeds proved by many animal and human cell culture models using <i>in vitro</i> and <i>in vivo</i> mechanisms.<br>]]></description> </item><item><title><![CDATA[Seaweed as a Functional Food to Increase Digestive Tract Health]]></title><link>https://www.benthamscience.comchapter/22341</link><description><![CDATA[Seaweeds are known as a delicacy and are a well-known source of vital dietary components. Seaweeds make up some of the most important sources of novel medicinal substances for human use. Additionally, as food, they have been proven to possess diverse health benefits. The distinctive characteristics of the marine environment where seaweed grows are thought to be primarily responsible for most of its traits. Compared to terrestrial plants, marine seaweeds contain higher amounts of health-promoting molecules and materials. Clinical trials and mechanistic research on isolated and extracted compounds from seaweeds have shown potential benefits to gastrointestinal health. The present review emphasizes the major seaweed compounds having nutritive value with special reference to the potential to improve gastrointestinal disorders and gut health.<br>]]></description> </item><item><title><![CDATA[Natural Dentin Remineralizing Agents]]></title><link>https://www.benthamscience.comchapter/22243</link><description><![CDATA[Dentin remineralization is vital for maintaining oral health and preventing tooth decay. Natural dentin remineralizing agents have gained significant attention as a promising alternative to synthetic remineralizing agents due to their biocompatibility, low cost, and minimal adverse effects. This book chapter provides a comprehensive overview of various natural dentin remineralizing agents and their potential applications in dental therapy. The mechanisms underlying the remineralization process, the properties and sources of natural dentin remineralizing agents, and the techniques used for their extraction and formulation are discussed. Additionally, the in vitro and in vivo studies investigating the effectiveness of natural dentin remineralizing agents in restoring tooth mineralization and preventing dental caries are highlighted. Finally, the future prospects and challenges are discussed. This book chapter provides a valuable resource for dental professionals, researchers, and students interested in natural dentin remineralization and its potential applications in dentistry.&nbsp;<br>]]></description> </item><item><title><![CDATA[Common Surgical Procedures in Geriatric Patients]]></title><link>https://www.benthamscience.comchapter/22214</link><description><![CDATA[Demographic studies show that life expectancy for people in the USA has been trending upwards for the past several decades. As the population ages, the number of geriatric patients who will require surgery has also increased. Information from the National Hospital Discharge Survey reported that in 2006, 35.3% of all inpatient procedures and 32.2% of all outpatient procedures were in patients aged 65 and older. Common elective surgeries in elderly patients include cataract and lens procedures, spinal fusions and laminectomies, and total or partial hip and knee replacements. Common urgent surgeries in this population include thoracic and abdominal cancer resections, breast and prostate cancer resections, and cholecystectomies. Finally, common emergency surgeries in the elderly population include hip fracture repairs and other geriatric traumas.&nbsp;<br>]]></description> </item><item><title><![CDATA[Geriatric Pain Patient]]></title><link>https://www.benthamscience.comchapter/22205</link><description><![CDATA[Chronic pain is a major cause of physical disability, poor mental health, and decreased quality of life [1,2]. The burden of chronic pain is reflected in increased medical care utilization and consequently increased healthcare costs, which are estimated at an astounding $560 billion per year [3]. CDC estimates from 2019 reveal that while 20.4% of adults in the USA live with chronic pain, the prevalence increases with advancing age [4]. 30.8% of people aged 65 years and above had chronic pain while 11.8% of them had high-impact chronic pain, which is defined as pain that causes significant restriction of self-care, social and work-related activities [5]. The impact of chronic pain is more severe in the elderly; older adults report poorer physical health and disability in comparison to younger adults [6-8]. Chronic pain in the elderly is also associated with poorer sleep, cognitive decline, dementia, and death [9-13]. With the projected increase in the elderly population in the US every year, the burden of chronic pain is only expected to increase. This chapter outlines the physiologic and pharmacologic changes that happen with ageing, the major causes of chronic pain in the elderly, as well as the myriad of treatment options available with a focus on pharmacotherapy, behavioral and alternative therapies, and interventional pain therapies. The focus of treatment is not only targeted towards reducing pain but special considerations should be made to minimize the cognitive effects of polypharmacy in light of multiple comorbidities and promote mental well-being and functional independence [14].<br>]]></description> </item><item><title><![CDATA[Subject Index]]></title><link>https://www.benthamscience.comchapter/22106</link><description><![CDATA[]]></description> </item><item><title><![CDATA[Essential Oils’ Biosynthesis and their Application]]></title><link>https://www.benthamscience.comchapter/22101</link><description><![CDATA[Essential oils are natural plant products that have a wide range of applications in various fields like medicine, flavors, fragrance, etc. Their wide range of uses benefits people by exhibiting a variety of diverse properties like anti-allergic, antiinflammatory, antiviral, antibacterial, insect repellent, anticancer, anti-oxidant, and many more. They are also crucial to plants in terms of function. They are aromatic and are present in plants inside specialized cells or glands. Their biosynthesis occurs in the leaves and is present inside them until flowering. After the flowering of the plant, these oils get transferred to the flowers. These essential oils can be extracted using a variety of techniques, including solvent applications, steam distillation, and more. The quality and amount of essential oils in plants are affected by a variety of circumstances. These factors include the development stage of plants, the effect of UV radiation, the effect of Arbuscular mycorrhizal fungi, the effect of light quality, the effect of salt stress, and the effect of fertilizers.<br>]]></description> </item><item><title><![CDATA[Plant as Potential Resources for Efficacious Essential Oils: Underpinning Aromatherapy Evolution]]></title><link>https://www.benthamscience.comchapter/22099</link><description><![CDATA[The basis of healthcare has been medicinal plants from the dawn of humanity. For over 4000 years, people have carefully documented and passed down through generations the various ways in which these have been utilized. The Indian Vedic literature, which dates to roughly 2000 BC, contains a list of around 700 compounds. Cinnamon, spikenard, ginger, myrrh, coriander, and sandalwood are a few of these. Since ancient times, aromatic plant parts and oils have been used for their therapeutic and culinary characteristics, as well as to produce incense, perfumes, cosmetics, and for incense sticks. Ritual use was widespread in early cultures, where it served both sacred and therapeutic objectives that were intricately intertwined. Since prehistoric times, plant essential oils have been utilized in foods, aromatherapy, perfumes, cosmetics, spices, and alimentation. They have also been applied in other medical procedures and phytotherapy. In the current era of pharmaceutical science, interest in herbal medicines has grown relative to conventional or synthetic treatments because they are more affordable, more widely accepted, compatible with human physiology, and have fewer adverse effects. The medicinal properties and applications of an expanding number of emerging essential oils have been researched and documented by pharmacists. The interest in analysing their bioactivity has progressed owing to their widespread use, particularly the recently investigated antibacterial, antioxidant, anticancer, and antidiabetic effects. The traditional Indian or Ayurvedic system of medicine, as well as other ecumenical customary systems, would be transformed if plant predicated knowledge were to be incorporated. The uses of numerous plants for therapeutic, medical, aesthetic, psychological, olfactory, massage, aromatherapy, and other associated issues are examined in this chapter.<br>]]></description> </item><item><title><![CDATA[Subject Index]]></title><link>https://www.benthamscience.comchapter/21907</link><description><![CDATA[]]></description> </item><item><title><![CDATA[<i>In vitro</i> Regeneration and Conservation of the Medicinal and Aromatic genus Kaempferia: An Overview]]></title><link>https://www.benthamscience.comchapter/21903</link><description><![CDATA[Genus Kaempferia comprises about 124 species distributed in Southeast Asia and is well known for it's diverse medicinal, nutritional and industrial values. The plants of the genus are rhizomatous, perennial, and oil-yielding plants; some are also used as spices. The essential oil obtained from the plants has a considerable market value worldwide. The rhizomes of these plants were used in traditional medicine due to the presence of diverse bioactive compounds and used to treat urinary tract infections, fever, cough, hypertension, metabolic disorder, asthma, rheumatism, epilepsy, skin diseases, etc. Seed dormancy, seasonal outgrowth and seed made through crosspollination were found to be non-viable, which are the prime limitations of ex situ conservation regarding this genus. To overcome this type of problem, in vitro tissue culture is the way to get the plants available over the year without any limitations. This chapter is based mainly on exploring those bioactive compounds containing species of the genus Kaempferia, and obtaining an alternative resource of phyto-compounds for use in pharmaceuticals and conserving them through an artificial way to get them throughout the year without exploiting the area and genotypic alteration.<br>]]></description> </item><item><title><![CDATA[<i>In Vitro</i> Propagation of Yam as a Medicinal Plant]]></title><link>https://www.benthamscience.comchapter/21897</link><description><![CDATA[Yam (Dioscorea spp.), a tropical monocot flowering, perennial multispecies crop, belongs to the family Dioscoreaceae. It is a valuable source of medicines and food security crops in yam-growing regions in Asia, Africa, and southern American countries. More than 600 yam species are widely cultivated in tropical and subtropical countries and used as food and medication for various human diseases. It provides big starchy tuberous roots as a source of carbohydrates, protein, antioxidants, minerals, and vitamins. It is also high in vitamin C, B6, manganese, potassium, and antioxidant compounds, which nourish and protect against oxidative cell damage in the human body. In addition, they are rich in potent plant compounds, including anthocyanins, a color-producing chemical that helps to reduce blood pressure and inflammation and protect against cancer and diabetes. Exceptionally, yam is an excellent crop for food security and human health. Micropropagation of medicinal yam is essential for the large-scale multiplication and conservation of endangered species. So far, in micropropagation of medicinal yam spp., very few studies have been conducted. These studies used axillary buds, nodal cuttings, mature, immature leaves, and shoot tips as explants for micropropagation. Several tissue culture techniques are available for micropropagation of yam, especially direct and indirect organogenesis for in-vitro propagation for large-scale generation of plantlets.<br>]]></description> </item><item><title><![CDATA[Micropropagation Studies on Genus Cissus A Review]]></title><link>https://www.benthamscience.comchapter/21886</link><description><![CDATA[The genus Cissus Linn. belongs to the Family Vitaceae (formerly Ampelidaceae) and comprises about 350 species distributed all over the world, having rich phytochemicals with medicinal as well as commercial value. This genus is a storehouse of large varieties of phytochemicals such as alkaloids, flavonoids, and phytosterols, making this genus pharmaceutically important. Some species contain high quantity of calcium ions in their stem extract, which is possibly responsible for their bone healing activity. In vitro propagation of plantlets provides the opportunity to conserve endangered species as well as to use the beneficial species without disturbing their natural habitat. The present review comprises in vitro protocols used to conserve the species, exploit and enhance useful metabolites. The whole plant, parts and metabolites isolated from in vitro cultures of Cissus species may be used further for pharmaceutical purposes.<br>]]></description> </item><item><title><![CDATA[Therapeutic Scope and Application of Mushroom-Derived Pharmacoactives in Enhancing Health]]></title><link>https://www.benthamscience.comchapter/21846</link><description><![CDATA[In the present era, the notion that “prevention is better than cure” has gained impetus with increased incidences of infectious and degenerative lifestyle diseases. Recent years have seen many people choosing functional food such as probiotics, plant-based nutritional supplements, and their normal dietary needs. Studies have shown significant health benefits in using these nutraceuticals as they aid in the body's general well-being. Among food varieties, edible mushrooms have also become a functional dietary food. It has been used as a source of nutrition in many parts of the world. Oriental medicine has been using mushrooms as a component in various medicinal concoctions for several decades. Today, with the advent of scientific knowhow, around 2,000 edible mushrooms have been identified; among them, 700 possess bioactive compounds. Both In vitro and In vivo studies have shown immunomodulatory effects via the regulation of innate, complement-mediated, and adaptive immunity by enhancing the active mechanisms of immune systems such as the macrophages, IL, TNF-α, IFN-γ, NO, and the complement system. The possibility of modulating these immune system players by the bioactives may pave the way to side-effect-free anticancer and immunosuppressant drugs. Recent studies have also elucidated the neuroprotective effect induced by mushroom-derived compounds through ROS scavenging and antioxidant activity. This chapter highlights the recent findings and the importance of these mushroom-derived compounds and their anti-inflammatory, anticancerous antioxidant, and immunomodulatory roles.<br>]]></description> </item><item><title><![CDATA[Subject Index]]></title><link>https://www.benthamscience.comchapter/21758</link><description><![CDATA[]]></description> </item><item><title><![CDATA[Sharing is Caring: Drug Repurposing among Leading Diseases]]></title><link>https://www.benthamscience.comchapter/21757</link><description><![CDATA[The process of drug development is time-consuming and resource-intensive, but drug repurposing offers an alternative by using already approved drugs to treat different diseases. Drug repurposing candidates can be identified through computational and experimental approaches, which are often combined. Traditionally, drug repurposing is considered when developing a custom drug is not feasible, but recent findings regarding the cross-talk between cellular mechanisms and pathways that are altered among disease states suggest that multipurpose drugs may be the key to simultaneously treating multiple diseases. This chapter reviews published reports on drug repurposing for five of the most threatening diseases to human health today: Alzheimer's disease, arthritis, diabetes mellitus, cancer, and COVID-19, highlighting promising candidates, challenges, and potential future directions for research.<br>]]></description> </item><item><title><![CDATA[Human Diseases and Recent Biotechnology Breakthroughs in Curbing Diseases]]></title><link>https://www.benthamscience.comchapter/21755</link><description><![CDATA[Medical biotechnology represents a field in continuous progress and today has revolutionized how illnesses are diagnosed and treated. A look at the latest medical biotechnological breakthroughs shows how biotechnology innovations are changing medicine. Recently, we saw how biotechnology affected efforts to combat the coronavirus disease 2019 (COVID-19) pandemic on the world's health. The scientific community has been working assiduously to develop effective treatments for the prevention and management of other diseases, such as cancer, human immunodeficiency virus (HIV), cardiovascular disease, diabetes mellitus, and neurodegenerative disorders such as Alzheimer's disease, along with other dementia variants that stand out among the leading causes of mortality worldwide. This effort has recently resulted in the development of RNA vaccines. Some of the most promising biotechnological developments include gene therapy to alter an individual's genetic makeup through diverse techniques, immunotherapeutic methods that bolster the body's natural immune defense mechanisms, and precision medicine strategies in which treatment is personalized to a patient's genetic profile. This chapter provides an overview of the most prevalent and deadly human diseases with a focus on recent biotechnological breakthroughs.<br>]]></description> </item><item><title><![CDATA[Role of Gut Microbiota in Neuroinflammation and Neurological Disorders]]></title><link>https://www.benthamscience.comchapter/21741</link><description><![CDATA[The prevalence of neurological diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and Multiple sclerosis (MS) are growing in the world, but their pathogenesis is unclear and effective treatment does not exist. Neuroinflammation is associated with many neurodegenerative mechanisms involved in neurodegenerative diseases. The human gut microbiota is an aggregate of microorganisms that live in the gastrointestinal tract (GIT) that plays a crucial role in maintaining human health and the pathogenesis disease condition. The microbiota can affect neuronal function through neurotransmitters, vitamins, and neuroactive microbial metabolites like shortchain fatty acids. The change in gut microbiota architecture causes increased permeability of the intestine and immune system activation, contributing to systemic inflammation, neurological injury, and eventually neurodegeneration. Available data suggest that the microbiota send signals to the central nervous system (CNS) by activating afferent neurons of the vagus nerve via neuroendocrine and neuroimmune pathways. The molecular interaction between the gut/microbiome and CNS is complex and bidirectional, ensuring gut homeostasis and proper digestion. Evidence suggests that dysfunction of the gut-brain axis could be a significant factor leading to many disorders of CNS. In this chapter, we explore how the gut microbiome may affect brain function and the development of neurological disorders. In addition, we are also trying to highlight the recent advances in improving neurological disease by supplemental probiotics and faecal microbiota transplantation via the concept of the gut-brain axis to combat brain-related dysfunction.<br>]]></description> </item><item><title><![CDATA[Recent Drugs Tested in Clinical Trials for Alzheimer´s and Parkinson´s Diseases Treatment: Current Approaches in Tracking New Drugs]]></title><link>https://www.benthamscience.comchapter/21739</link><description><![CDATA[Affecting more than 50 million people worldwide and with high global costs annually, neurological disorders such as Alzheimer's disease (AD) and Parkinson’s disease (PD) are a growing challenge all over the world. Globally, only in 2018, AD costs reached an astonishing $ 1 trillion and, since the annual costs of AD are rapidly increasing, the projections estimate that these numbers will double by 2030. Considering the industrial perspective, the costs related to the development of new drugs are extremely high when compared to the expected financial return. One of the aggravating factors is the exorbitant values for the synthesis of chemical compounds, hindering the process of searching for new drug candidates. In the last 10-year period, an average of 20 to 40 new drugs were approved per year, representing a success rate of less than 6%. However, the number of referrals for new drug orders and/or applications remained at approximately 700 each year, reinforcing the difficulty in the process of identifying and developing novel drugs. Regarding neurodegenerative diseases, the FDA (USA) approved 53 new therapies in 2019, including 48 new molecules and, from these, three are medicines and two are vaccines. The main drugs recommended for the treatment of these disorders are included in the following classes: Dopamine supplement (Levodopa), Monoamine oxidase (MAO) inhibitor (Selegiline, Rasagiline), Dopamine agonist (Apomorphine, Pramipexole), and Acetylcholinesterase inhibitor (Donepezil, Rivastigmine, Galantamine). Additionally, the current pharmacological treatments are not able to cure these patients and considering the etiological complexity and the prevalence of neurological disorders, scientists have a great challenge in exploring new therapies and new molecules to find an adequate and viable treatment for these diseases. Clinical trials are essential in this process and thus, this chapter describes the most important drugs that were targets of phase III and IV clinical studies in the last five years, associated with the most common neurological disorders worldwide, AD and PD. Information about mechanisms of action, experimental studies in other diseases that support their use, and chemical structure of the drugs are included in this chapter. Additionally, nature as a source of valuable chemical entities for PD and AD therapeutics was also revised, as well as future advances in the field regarding tracking new drugs to get successful results and critical opinions in the research and clinical investigation.<br>]]></description> </item><item><title><![CDATA[Stem Cells-Based Technological Innovation in Tissue Engineering]]></title><link>https://www.benthamscience.comchapter/21646</link><description><![CDATA[Stem cells are a category of cells with self-renewal and multi-lineage differentiation capacity, which have been recognized as advantaged sources for tissue engineering and regenerative medicine. To date, stem cells and their derivatives alone or combined with biomaterials have aroused extensive and sustained attention to investigations in the field of fundamental research and clinical practice. In recent years, a series of novel technologies have been involved in stem cell-based cytotherapy, such as three-dimensional (3D) printing, organoid research, and multitudinous kinds of gene-editing technologies, which collectively facilitate the development of tissue engineering for disease administration. In this chapter, we summarized the rudimentary knowledge of the aforementioned new technologies, together with the promising perspective and the concomitant challenges, which would help increase the cognition of technological innovation for stem cell-based investigations and remedies in the future.<br>]]></description> </item><item><title><![CDATA[Promising Pharmaceutical Compounds of Marine Shellfish: Their Chemistry and Therapeutic Applications]]></title><link>https://www.benthamscience.comchapter/21601</link><description><![CDATA[This chapter deals with the promising bioactive compounds of marine shellfish viz. crustaceans, molluscs, and echinoderms. Among the marine crustaceans, the extracts of shrimps and crabs containing astaxanthin showed major bioactivities. On the other hand, among molluscs, gastropods possessed the maximum number of secondary metabolites and associated bioactivities compared to the bivalves and cephalopods. Further, among echinoderms, the asteroids and holothurians showed maximum number of secondary metabolites compared to their counterparts viz. echinoids and crinoids.<br>]]></description> </item><item><title><![CDATA[Promising Pharmaceutical Compounds of Marine Cnidarians: Their Chemistry and Therapeutic Applications]]></title><link>https://www.benthamscience.comchapter/21598</link><description><![CDATA[This chapter deals with the promising secondary metabolites of the different constituents of marine cnidarians viz. hydrozoan medusae, scyphozoan medusae and soft corals and their bioactivities. Among the chemical classes of compounds, terpenoids ranked first and cytotoxicity of these compounds was the major activity.&nbsp;<br>]]></description> </item><item><title><![CDATA[Promising Pharmaceutical Compounds of Marine Plants: Their Chemistry and Therapeutic Applications]]></title><link>https://www.benthamscience.comchapter/21596</link><description><![CDATA[This chapter deals with the promising marine bioactive compounds of marine plants such as, seaweeds, seagrasses, mangroves, and halophytes; and their chemistry and therapeutic applications. Among the different constituents, the seaweeds in general and brown and red algae exhibited a variety of bioactivities followed by mangroves, seagrasses, and halophytes in that order.<br>]]></description> </item><item><title><![CDATA[Micropropagation of Actinidia deliciosa (A. Chev.) C.F.Liang & A.R.Ferguson]]></title><link>https://www.benthamscience.comchapter/21571</link><description><![CDATA[Actinidia deliciosa, commonly known as Kiwifruit (Chinese gooseberry), belongs to the family Actinidiaceae. The edible and fleshy fruit has gained popularity over the past few decades owing to its high nutritive value, and medicinal and potential curative properties. The fruit is rich in vitamin C, folate, vitamin E, dietary fibers, antioxidants, enzymes, phytonutrients, etc. The presence of actinide in Kiwis helps in regulating gastric abnormalities, hypertension, cardiovascular inflammation, hemostatic disorder, and abnormal glucose metabolism, and prevents cancer. Consequently, the fruit holds a considerable market value that has led to the establishment of industrial organizations comprising growers and distributors. For the purpose of fulfilling the constant market demands, it is crucial to maintain quality standards, timely production, and an abundance of planting material. This chapter discusses the various in vitro propagation methods, including diverse and detailed approaches for both the direct and indirect organogenesis for large-scale production of good-quality kiwi plants, along with ex vitro hardening and acclimatization processes. It is apparent that the plant tissue culture techniques can be suitably applied for the mass production of kiwi fruit, while other in vitro manipulations and further biological research are needed to improve the field performance and post-harvest life of the fruit and its plant.<br>]]></description> </item><item><title><![CDATA[A Review of Tissue Culture Studies on Withania somnifera (L.) Dunal - An Important Medicinal Plant]]></title><link>https://www.benthamscience.comchapter/21558</link><description><![CDATA[Withania somnifera, commonly known as 'Indian ginseng', is a highly important and valuable medicinal plant in traditional family medicine, containing a variety of medicinal bioactive molecules for over 3,000 years. Various medicinal properties of plants are attributed to steroidal lactones (withanolides) present in plants. Its commercial cultivation is hampered by low seed viability and germination rates. Tissue culture techniques can play an important role in the preservation, clonal propagation, and qualitative improvement of this medicinal plant. In vitro shoot differentiation and micropropagation of W. somnifera from various small excised explants such as hypocotyl and cotyledon leaves, shoot tips, nodes and internodes. Optimal normal growth, reproduction, and development of W. somnifera through the in vitro processes of morphogenesis of many tissues may differ in several different plants based on key plant nutrient requirements. The current review provides a comprehensive study on the development of W. somnifera tissue culture research activity. It also discusses the medicinal properties of this plant.<br>]]></description> </item><item><title><![CDATA[Animal Models in Dentistry]]></title><link>https://www.benthamscience.comchapter/21469</link><description><![CDATA[Dentistry is a medical specialty that deals with teeth and gums, and animal models play an important part in its research and teaching. The use of animal models dates back centuries, and animals such as dogs, cats, rabbits, and horses have been utilized to investigate dental diseases and the anatomy and function of teeth. The selection criteria for animal models include their human-like physiology, the accessibility of relevant genetic resources, and usability and affordability. Animals are employed for research on various dental conditions, such as periodontal disease, dental caries, and oral cancer. Periodontitis is a dangerous gum infection that can lead to tooth loss, frequently brought on by a lack of oral hygiene. Dental caries are studied in animal models, and new preventative and therapeutic methods are explored. Oral cancer is studied, and its course and therapies are tested using animal models. The use of test methods specified by the International Organization for Standardization has helped to evaluate the biological reaction of various dental substances. Hamsters, which are usually correlated to mice, are employed to examine the features of periodontal and cariogenic diseases. Disease transmission can be studied in these animals as well. The dog periodontium is the one that most closely resembles that of humans. Canine periodontal disease is highly reflective of its human counterpart, and gingival recession is a hallmark of periodontitis in dogs, as it is in humans. Although animal models have been instrumental in the field of dentistry, there is not a single animal model that adequately replicates human soft and hard tissues, and it is crucial to choose an experimental model in light of the goals of the study.<br>]]></description> </item><item><title><![CDATA[An Overview of Current and Future Applications of Robotics In Surgical Operations]]></title><link>https://www.benthamscience.comchapter/21303</link><description><![CDATA[Technology has changed almost all aspects of our life. Similarly, in the medical field, the new technology is Robotic surgery. Robotic surgery involves employing robots in the process of surgery. The employed robot, known generally as the surgical robot, is self-regulating, partially or entirely computer-controlled, and can be programmed as required for the surgery. As different surgical robots are employed for different types of surgery, robotic surgery improves patient care and ensures better treatment than regular surgery. The purpose of this article is to provide an outline of the main ideas of robotic applications used in surgery. This article aims to provide an overview of robotics's current and future applications in surgical operations and the advantages and disadvantages of surgical robots.&nbsp;<br>]]></description> </item><item><title><![CDATA[Nanocarriers: Promising Vehicles for Controlled Bioactive Drug Delivery in Current Medical System]]></title><link>https://www.benthamscience.comchapter/21253</link><description><![CDATA[<div>Nanomaterials have been widely employed in the medical profession in</div><div>recent decades, thanks to the rapid development of nanotechnology. Their distinctive</div><div>physical and chemical qualities, such as minimal size, functionalized surface</div><div>characteristics, stable interactions with ligands, high carrier capacity, and ease of</div><div>binding with both hydrophilic and hydrophobic substances have made them ideal</div><div>platforms for the target-specific and controlled delivery of micro-and macromolecules</div><div>in disease therapy and have revealed an excellent potential pertaining to clinical entities</div><div>with the goal of fine-tuning bioavailability, bioefficacy, and pharmacokinetics. The</div><div>absorption, post-administration stability as well as bioavailability of bioactive drugs</div><div>and other medicinal substances are the key issues. Some critical medications have low</div><div>gastrointestinal absorption and permeability in their active form, are inactivated by pH</div><div>and temperature fluctuations and cause catastrophic off-target and undesirable side</div><div>effects. Certain investigations have also indicated that active efflux mechanisms affect</div><div>the absorption of some presently integrated compounds with structural alterations</div><div>across the intestinal wall. Furthermore, intestinal bacteria and/or enzymes break down</div><div>fragile structures of active substances into a variety of metabolites, each of which has</div><div>different bioactivity than the original chemical compound. Nanocarrier-mediated</div><div>distribution improved their solubilization potential, changed absorption paths, and</div><div>reduced metabolic breakdown by gut bacteria and enzymes. Combining</div><div>nanobiotechnology with current therapeutic techniques has shown to be effective in</div><div>bringing innovative and previously rejected bioactive substances to the market for</div><div>treating a myriad of diseases and disorders. As a result, we predict that nanotechnology</div><div>will play a larger role in illness detection and treatment in the future, perhaps helping to</div><div>overcome bottlenecks in current medical approaches. This chapter focuses on a</div><div>comprehensive discussion of strategies and applications of nanoengineered delivery</div><div>systems along with the pharmacokinetic properties and drug-delivery mechanism of these nanocarriers. Probably associated drawbacks, challenges, future advancements,</div><div>and scopes of nanocarriers in clinical care are also highlighted.</div>]]></description> </item><item><title><![CDATA[Medicinal Plants: Traditional Trends to Modern Therapeutics]]></title><link>https://www.benthamscience.comchapter/21236</link><description><![CDATA[<div>Medicinal plant therapies are becoming more common, as more people seek</div><div>natural cures and health approaches devoid of synthetic chemicals' adverse effects. The</div><div>biological and pharmacological potential of plants is studied and utilized all around the</div><div>globe for various purposes including the treatment of infections and diseases owing due</div><div>to bioactive compounds in plants produced as a result of secondary metabolism. The</div><div>study of medicinal plants is helpful in clinical trials to find pharmacologically useful</div><div>chemicals, and this method has produced thousands of valued medicines. Opium,</div><div>aspirin, quinine, and digoxin are some examples. Plants possess a large number of</div><div>bioactive compounds. On the basis of their chemical structure, they are divided into</div><div>four classes: alkaloids, flavonoids, tannins, and terpenes. Plants can now be turned into</div><div>“factories” that create therapeutic proteins, vaccines, and many more products for use</div><div>in the production of biotech pharmaceuticals, medications, and therapies. This chapter</div><div>discusses the diversity and importance of medicinal plants in various sectors as well as</div><div>highlights the successful drug products produced by the said entities and their future</div><div>trends.<br></div>]]></description> </item><item><title><![CDATA[Genetic Transformation in Medicinal Plants]]></title><link>https://www.benthamscience.comchapter/21230</link><description><![CDATA[<div>Secondary metabolites including terpenoids, terpenes and enzyme cofactor</div><div>have significant importance in medicinal use. Extraction of plant-based compounds is</div><div>quite challenging by conventional methods. Biotechnological methods like genetic</div><div>engineering and In Vitro techniques, proteomics, genomics and biochemical pathways</div><div>are being employed to serve the purpose. Different organic compounds including</div><div>enzymes, recombinant proteins, vaccines, antibiotics and anticancer have been</div><div>successfully extracted through the genetic transformation of tomato, rice, corn, soybean</div><div>and Nicotiana tabacum. This report describes different biotechnological approaches</div><div>with a special focus on tissue culture and genetic transformation methods for the</div><div>investigation of medicinal plants and their important role in our economic industry.</div>]]></description> </item><item><title><![CDATA[Abdominal Examination]]></title><link>https://www.benthamscience.comchapter/20986</link><description><![CDATA[The abdominal examination consists of four basic components: inspection, palpation, percussion, and auscultation. It is important to begin with the general examination of the abdomen with the patient in a completely supine position. The present chapter is mainly focused on how to examine abdominal systematic.&nbsp;<br>]]></description> </item><item><title><![CDATA[Semi-Supervised Algorithms]]></title><link>https://www.benthamscience.comchapter/20893</link><description><![CDATA[Semi-supervised learning, or SSL, falls somewhere between supervised and unsupervised learning. The algorithm is provided with some supervision data in addition to unlabeled data. There are two primary learning paradigms in it. Transductive education aims to use the trained classifier on unlabeled instances observed during training. This kind of algorithm is mainly used for node embedding on graphs, like random walks, where the goal is to label the graph's unlabeled nodes at the training time. Inductive learning aims to develop a classifier that can generalize unobserved situations during a test. This chapter details different semi-supervised algorithms in healthcare.<br>]]></description> </item><item><title><![CDATA[Cytotoxic Phytochemical library of Rosmarinus Officinalis]]></title><link>https://www.benthamscience.comchapter/20705</link><description><![CDATA[Globally, the prevalence of cancer has escalated at an alarming rate, and it has become a major health problem. The World Health Organization reported that one in six deaths is due to cancer. Despite the advantages of current chemotherapy available for cancer treatment, the development of resistance and severe side effects continuously insist cancer research focus on the discovery of new entities, especially from natural sources. In the last few decades, varieties of dietary herbs have been explored for their cytotoxic potential. Rosmarinus officinalis, a well-known culinary herb commonly known as rosemary, is not only used to enhance the flavour but also possesses medicinal values. The Rosmarinus officinalis plant extract and its essential oil are packed with different phenolic acids and terpenoids. Rosmarinus officinalis has anti-cancer, anti-proliferative, protective, anti-inflammatory, and anti-oxidant properties, according to several in vitro and in vivo studies. The antitumor activity of Rosmarinus officinalis is correlated with different molecular mechanisms such as reactive oxygen species scavenging, the on-co-suppressor gene expression, apoptosis, and immunomodulatory response regulation. So this chapter mainly focuses on the cytotoxic activities of Rosmarinus officinalis and the molecular mechanisms responsible for their anticancer activities. Also, possibilities of utilising the extracts, essential oils, and phytochemicals of Rosmarinus officinalis as potential therapeutic agents or complementary therapies with chemotherapeutic agents for cancer treatment have been discussed.&nbsp;<br>]]></description> </item><item><title><![CDATA[Human Topoisomerases and Caspases: Important Targets in Cancer Therapy]]></title><link>https://www.benthamscience.comchapter/20701</link><description><![CDATA[Cancer has always remained a major challenge to humanity with its rising morbidity and mortality rate making it uncontrollable. Current treatments for cancer offer limited efficacy and suffer from serious side effects. With a focus on making treatment safer and more effective, there is a need to identify novel targets and potent drugs for these targets. Recent years have witnessed significant progress in the discovery of targeted cancer therapy. On-going research in this field suggests that human topoisomerases and caspases are important molecular drug targets for anti-cancer drug development. Topoisomerases are DNA processing enzymes essentially required to maintain DNA topology during transcription, replication, recombination and chromosomal decatenation. Several new chemical classes of topoisomerase inhibitors including natural product derivatives are in clinical trials for the treatment of various human cancers. Several topoisomerase inhibitors such as topotecan, irinotecan, camptothecin, teniposide and doxorubicin are clinically approved for various cancers such as colon cancer, lung cancer, breast cancer, and many more. However, many of these inhibitors have also been associated with serious side effects during chemotherapy. Emerging data in recent years also suggests the role of topoisomerase inhibition in immunogenic cell death and activating anticancer immune responses making them potential combinatorial modalities for cancer immunotherapy. Caspases [1-12] belong to the family of cysteine-aspartic proteases responsible for the execution of cell death in apoptotic cells. Caspases play an important role in various non-lethal biological processes like cell proliferation, cell differentiation, intercellular communication, and cell migration. The dysregulation of apoptotic signalling pathways is considered one of the hallmarks of cancer. Hence the focus of cancer therapy is correcting this aberrant behaviour. Natural products such as alkaloids, flavonoids, diterpenoids, sesquiterpenes, and polyphenolics have been reported with various anticancer properties. In this chapter, we have discussed topoisomerases and the regulation of caspase functions through direct or indirect methods for anticancer drug discovery.&nbsp;<br>]]></description> </item><item><title><![CDATA[The Traditional Immune Boosting Recipes]]></title><link>https://www.benthamscience.comchapter/20696</link><description><![CDATA[The immune system is amazingly complicated and vital for our survival. Several different systems and cell types of our body work effortlessly in ideal synchrony throughout the body to fight off pathogens and clear up dead cells. Our immune systems perform an implausible job by putting up a wall that can safeguard the disease-causing microorganisms. Our immune system requires equilibrium to function smoothly, so a person must eat and drink healthy balanced foods for getting energy and nutrients. The immunity related diseases may occur due to several factors such as seasonal change, environment factors, virus attacks, and simple stress. To combat these, we need to consume immunity-boosting foods and nutrients rich in antioxidants like Alium sativum, Alium cepa, Citrus limon, Withania somnifera,Moringa oleifera, Curcuma longa, etc., which can build up the immunity. The traditional system of medicine like Ayurveda and Siddha system of medicine quoted several traditional immune-boosting recipes like Maha- sudharshnachoornam, Talisadichoornam, Dhanavantam, Gulika-churnam, sitophaladichoornam, etc. Several times it is proven that lifestyle and dietary changes can result in a better immune system. A healthy lifestyle includes consuming foods which help in boosting immunity. In addition to keeping a balanced diet in our daily life, there is a necessity for traditional immunityboosting agents simultaneously. Traditional immunity-boosting agents are usually rich in vitamins, antioxidants, and other minerals and the requisite nutrients for maintaining equilibrium in the immune system. In this chapter, detailed information about Traditional immunity-boosting agents will be discussed.<br>]]></description> </item><item><title><![CDATA[Application of Main Group Elements and Their Compounds in Medicine]]></title><link>https://www.benthamscience.comchapter/20661</link><description><![CDATA[]]></description> </item><item><title><![CDATA[Biological Functions of d- and f- Block Elements]]></title><link>https://www.benthamscience.comchapter/20660</link><description><![CDATA[]]></description> </item><item><title><![CDATA[Biological Functions of Elements of Main Groups]]></title><link>https://www.benthamscience.comchapter/20659</link><description><![CDATA[]]></description> </item><item><title><![CDATA[Isoxazole Derivatives as Potential Pharmacophore for New Drug Development]]></title><link>https://www.benthamscience.comchapter/20631</link><description><![CDATA[Isoxazoles are five-membered aromatic heterocyclic compounds in which oxygen and nitrogen atoms are present at positions 1 and 2 of the ring system. Isoxazole derivatives play a vital role due to their diverse biological activities, such as antimicrobial, antifungal, anti-viral, anti-tubercular, anti-epileptic, anti-diabetic, anticancer, anthelmintic, antioxidant, antipsychotic, antimalarial, analgesic, anti-inflammatory, etc. Isoxazole scaffold is present in various drug molecules, such as leflunomide (antirheumatic), valdecoxib (non-steroidal anti-inflammatory drug), and zonisamide (anti-convulsant). Similarly, isoxazole derivatives such as isocarboxazid act as monoamine oxidase inhibitors. It is used to treat symptoms of depression that may include anxiety, panic, or phobias. Whereas the isoxazole derivatives, including sulfamethoxazole, sulfisoxazole, and oxacillin, are used clinically for the treatment of bacterial infections. Isoxazole pharmacophore is also present in β-lactamase resistant antibiotics such as cloxacillin, dicloxacillin, and flucloxacillin. Cycloserine is a naturally occurring antibiotic that possesses isoxazole moiety with anti-tubercular, activity. This study focuses on the therapeutic potentials of isoxazole derivatives in new drug development.<br>]]></description> </item><item><title><![CDATA[Subject Index]]></title><link>https://www.benthamscience.comchapter/20627</link><description><![CDATA[]]></description> </item><item><title><![CDATA[Olive Oil Wastes Valorization for High Value Compounds Production]]></title><link>https://www.benthamscience.comchapter/20593</link><description><![CDATA[The consumption of olive oil is deeply rooted in human history and the production of olive oil contributes greatly to the economy of Mediterranean countries. Olive oil is generally extracted following three different methods; the traditional pressing method, two-phase decantation system and three-phase decantation system. These extraction processes generate mainly two different types of waste which are olive mill solid waste (OMSW) and olive mill wastewater (OMWW). Olive mill by-products are considered a major environmental hazard in Mediterranean regions as they are high in phenol, lipid and organic acid content. To eliminate this problem, valorization of these waste products is the need of the hour. Phytochemical compounds like phenols, and flavonoids are important and useful for pharmaceutical industries. Other than the recovery of these value-added compounds, olive waste can be used as animal feed and a source of clean energy. Biological treatment of these wastes reduces the percentage of phenols and organic acids and then it can be used in agricultural applications. The valorization strategies of olive mill wastes depend on factors like socio-economic conditions, and agricultural and industrial environments. In this chapter, the olive oil production process, phytochemical characteristics of generated waste and their environmental impact are discussed. This discussion also emphasized the available valorization techniques of olive oil by-products, their advantages, and disadvantages.<br>]]></description> </item><item><title><![CDATA[Marine Metabolites: An Untapped Resource for Combinatorial Approaches against Antimicrobial Resistance]]></title><link>https://www.benthamscience.comchapter/20470</link><description><![CDATA[<div>Antimicrobial resistance (AMR) in pathogens of clinical importance has been reported as the most commonly used antibiotics. The discovery of antimicrobial agents is in a sharp decline due to the high probability of rediscovery, high costs, and low income. Hence, the development of combinatorial antimicrobial approaches to treat AMR-related infections has gained greater attention in recent decades. Marine organisms are a rich source of structurally and chemically diversified bioactive compounds for drug discovery to address the emergence of antimicrobial resistance. Researchers have identified several bioactive metabolites from marine resources and reported on their pharmacological activities. Interestingly, marine-derived metabolites such as antimicrobial peptides, alkaloids, anthraquinones, and polysaccharides were shown to enhance the action of antibiotics by means of synergistic activity. However, numerous marine-derived compounds are yet to be evaluated for their inherent proficiency to increase the efficiency of the antibiotics and research in this regard is expected to save time, expenses and successful identification of potential compounds to treat AMR infectious diseases.&nbsp;<br></div>]]></description> </item><item><title><![CDATA[Immunomodulatory Plant Extracts and their Compounds. Evaluation of your Safety]]></title><link>https://www.benthamscience.comchapter/20386</link><description><![CDATA[Medicinal herbs have been in use for the management of human health, for prevention. as well as for the cure of human diseases since ancient civilizations. In recent times, the use of herbal drugs has increased in both developed and developing countries, because of the large chemical, pharmacological, and clinical knowledge of plant drugs and their derivatives, the development of new analytical methods for quality control, the development of new forms of preparation and administration of plant drugs and their derivatives and finally the relatively wide therapeutic margins with less frequent adverse effects. However, naturals are not a synonym for innocuous as many adverse effects can occur. In this regard, there are different levels of perceptions about the safety of medicinal herbs, varying from “completely safe” to “completely harmful”, although there is also a clear idea about its side effects depending on factors such as dosage, characteristics of the plant material and consumer-related factors. Because of this, medicinal plants need to be studied and effective and innocuous doses must be established. Nowadays, immunomodulatory drugs have gained a main role principally as a consequence of COVID-19 produced by the SARS-CoV-2 virus. Some South American plants frequently used in Argentine folk medicine such as Larrea divaricata and Ilex paraguariensis and others used all over the world like Tilia spp. and Coffeea Arabica are known to exert immune-enhancing effects. In this review, we discussed some reports about the immunological effect of the mentioned plants and their majority compounds, focusing on their efficacy and safety.<br>]]></description> </item><item><title><![CDATA[In silico Approaches to Tyrosine Kinase Inhibitors’ Development]]></title><link>https://www.benthamscience.comchapter/20288</link><description><![CDATA[Many cellular communications and cellular activities are regulated by a class of enzyme tyrosine kinases. Mutations or increased expression of these enzymes lead to many proliferative cancers as well as other non-proliferative diseases such as psoriasis, atherosclerosis and some inflammatory diseases. Hence, they are considered vital and prospective therapeutic targets. Over the past decade, considerable research work has been carried out to develop potential inhibitors against these tyrosine kinases. So far, a number of compounds have been identified successfully as tyrosine kinase inhibitors and many compounds were developed as drugs to treat tyrosine kinase-induced diseases. Behind the successful development of these inhibitors, many Computer Aided Drug Design (CADD) (in silico) approaches include molecular modelling, high throughput virtual screening against various chemical databases, and docking (both rigid and flexible method of docking). Further many studies identified the possible features which are responsible for tyrosine kinase inhibition activities for a number of series of compounds through the quantitative structure-activity/property relationship (QSAR/QSPR) process. In this review article, the structural characteristics, mechanism of action, and mode of inhibition of tyrosine kinases are discussed followed by the successful applications of a variety of in silico approaches in tyrosine kinase inhibitors development.<br>]]></description> </item><item><title><![CDATA[Application of Flow Cytometry in Biological Sciences]]></title><link>https://www.benthamscience.comchapter/20222</link><description><![CDATA[Flow cytometry is one of the sophisticated tools with its applications in different biological disciplines. It is potentially efficient in the characterization of mixed populations of cells present in biological samples, including blood cells, lymphocytes, microorganisms, sperms, cancer cells, metabolites, antibodies, DNA/RNA content, proteins, toxins, plant spores, etc. Flow cytometry is widely applied in the determination of cellular characteristics and cellular components profiling like cell size, intracellular pH, DNA, RNA, proteins, surface receptors, membrane potential, calcium, and others. Currently, flow cytometry is pragmatic in basic as well as applied plant research and plant industrial applications like plant breeding. Flow cytometry has been considered a reliable, rapid, efficient, and accurate tool for analysis of ploidy level and nuclear genome size estimation. It is also subjected to taxonomy to study population/subpopulation dynamics. Gender determination from pollen grain is also possible due to flow cytometry.&nbsp;<br>]]></description> </item><item><title><![CDATA[Subject Index]]></title><link>https://www.benthamscience.comchapter/20210</link><description><![CDATA[]]></description> </item><item><title><![CDATA[Probiotics and Oral Health]]></title><link>https://www.benthamscience.comchapter/20207</link><description><![CDATA[Humans are host to oral microbiomes in a positive relationship which is a critical determinant for regulating oral symbiosis. When the balanced condition is transformed into an acidic environment, the percentage. mutans streptococci and Lactobacillus species increase. However, to be beneficial in the oral cavity, probiotics must first aggregate and attach to the oral tissue, creating a protective barrier to prevent the colonisation of the pathogenic microorganisms. The growth and activity of probiotics are enhanced by nondigestive oligosaccharides, namely, prebiotics, which cannot be digested by the host but enhance the beneficial effects of probiotics by selectively stimulating the growth and activities of the probiotics.<br>]]></description> </item><item><title><![CDATA[Management of Children with Systemic Diseases]]></title><link>https://www.benthamscience.comchapter/20198</link><description><![CDATA[Significant oral problems are associated with many medical disorders. Close cooperation and consultation between the dentist and the child’s physician are essential to render optimum medical care. Prevention of oral disease is the primary consideration for these children. Medically compromised children can be challenging to treat and affect dental care [30]. To treat medically compromised patients safely, it is essential to Obtain a relevant and thorough medical history and understand the possible implications of the illness on dental treatment and the potential importance of the condition on treatment planning and the caries risk associated with the medical condition. With advances in medical treatment, significantly more children survive longer with more complex medical needs, and these children will present to the general dentist for dental treatment.<br>]]></description> </item><item><title><![CDATA[Hepatoprotective Phytochemicals: Isolation and Characterization from Plant Extracts]]></title><link>https://www.benthamscience.comchapter/20187</link><description><![CDATA[The liver is the body's primary organ responsible for metabolism and excretion. Oxidation, reduction, hydration, condensation, hydrolysis, conjugation, and isomerization are some of the metabolic routes used by the human liver to metabolise chemicals. Any of the aforementioned processes can be disrupted, resulting in liver cell damage or hepatotoxicity, which can lead to a variety of disorders. These disorders are linked to increased death rates over the world. Medicines, chemicals, dietary changes, and herb-induced liver injury via hepatotoxins can all cause hepatotoxicity. A number of herbal and herbomineral preparations are available in Ayurveda, the traditional Indian Medicine, which has been investigated for their hepatoprotective potential to treat different types of liver disorders. The present review is focused on different herbal plants that have the potential to cure hepatotoxicity.<br>]]></description> </item><item><title><![CDATA[Bioactive Compounds from Plants Having Hepatoprotective Activity]]></title><link>https://www.benthamscience.comchapter/20183</link><description><![CDATA[The liver plays an essential role in metabolic management, and detoxification associating the metabolisms of toxins, lipids, alcohols, carbohydrates and various drugs. It also plays a role in the immune response. However, some conditions, such as viral infections (hepatitis), inflammation, continuous liquor consumption, periodic use of antibiotic-related drugs, and non-alcoholic fatty liver illness, can produce free radicals and cytokines, enhance lipid peroxidation, and induce damage to hepatocytes. Hepatoprotective agents are often the treatment of choice to improve liver function and protect the liver from exposure to harmful compounds. Based on scientific reports, Silybum marianum, Moringa oleifera, Garcinia mangostana, Glycyrrhiza glabra, Mangifera indica, Amaranthus spinosus, Andrographis paniculata, Phyllanthus species (amarus, niruri, emblica), Curcuma species (longa, xanthorrhiza, manga), and Citrus species (aurantium, sinensis, unshiu, grandis) have been broadly administered for the liver ailments therapy through antioxidant-associated abilities. Impressive studies have exposed that the health-promoting outcomes of bioactive constituents derived from plants have often been applied to their antioxidant characteristics and raise the cellular antioxidant protection system, scavenge free radicals, suppress lipid peroxidation, stimulate anti-inflammatory capacity, and assure the liver from destruction. These compounds are chlorogenic acid, curcumin, quercetin, hesperidin, rutin, betalains, apigenin, silymarin, phyllanthin, mangiferin, α-mangostin, bellidifolin, ginsenosides, glycyrrhizin, lycopene, and andrographolide.<br>]]></description> </item><item><title><![CDATA[Hepatoprotective Role of Medicinal Plants]]></title><link>https://www.benthamscience.comchapter/20182</link><description><![CDATA[With its ability to self-regenerate, the liver is considered an important gland in the human body, performing essential functions such as the production of vital proteins, lipids, lipoproteins, glucose homeostasis as well as the production and secretion of vitamin stores and bile acids. Therefore, any impairment of the organ can lead to serious problems in our bodies. There are various forms of disorders associated with an unhealthy liver, which affect the liver in different ways and can be detected by observing various general symptoms and some specific diagnostic tests. To treat and control these hazardous effects on our bodies, various medicines are available in the market that are mainly derived from plants and plant products. As they have fewer side effects, herbal medicines have attracted much attention for alleviating various liver diseases while maintaining a healthy lifestyle. Moreover, nanobased delivery of natural products shows higher hepatoprotective activity than crude extracts. In this chapter, various hepatoprotective functions of medicinal plants and their nano-based drug delivery have been highlighted.<br>]]></description> </item><item><title><![CDATA[Hepatotoxicity]]></title><link>https://www.benthamscience.comchapter/20181</link><description><![CDATA[The largest organ in the human body is the liver which captures 2 to 3% of the human body weight, located on the right side of the anterior quadrant in the abdomen and below the anterior hemidiaphragm ribcage. It performs various important functions such as digestion of food, protein production, fluid production, detoxification of waste, etc. Liver injury known as liver trauma can be categorized into four types: hepatocellular, autoimmune, cholestatic and infiltrative. Drug-induced liver injury can match with any form of acute or chronic liver injury. Acute injury to the liver is mainly due to the action of cytochrome P450, which disintegrates drugs into electrophiles or free radicals; these reactive metabolites can covalently act on protein and unsaturated fatty acids for induction of lipid peroxidation which leads to calcium homeostasis or death. Toxicology of the liver is a complex concept that entails either concurrent as well as sequential events. These events determine the pathways, severity and effects of liver injury. Pharmacogenetics has made great progress in current years which indicates the creation of refined algorithms that take drug, host and environmental risk variables into account, allowing for the selection of better medicine based on accurate risk-benefit ratio calculations. In this chapter, we will discuss the anatomy, functions of the liver, types of liver injury, risk factors, and various treatment strategies for the treatment of liver diseases.<br>]]></description> </item><item><title><![CDATA[Nanofibers Approach for Gastro Retentive Cancer]]></title><link>https://www.benthamscience.comchapter/20155</link><description><![CDATA[Gastric cancer is the world's second leading cause of cancer-related death. Due to inadequate drug release and limited residence time at the absorption site, traditional oral dose forms have poor/low bioavailability. GRDDS is particularly useful for increasing the bioavailability of medications with a narrow absorption window in the gastrointestinal tract and for treating local diseases. Polymeric nanofibers have sparked a lot of attention among the numerous nanomaterials used in high-tech applications because of their simplicity of production, controlled size/shape, and characteristics. Filtration, barrier fabrics, wipes, personal care, and biological and pharmaceutical applications have been intensively researched with polymeric nanofibers. Electrospun polymeric nanofibers have recently been demonstrated to be a promising approach for drug delivery systems. The nanofiber method allows for stomach-specific drug release for a more extended period and improves local drug action due to the drug's extended contact time with the gastric mucosa. As a result, nanofiber technology appears to be a promising strategy for gastric retention drug delivery systems.&nbsp;<br>]]></description> </item><item><title><![CDATA[Cancer Pathophysiology]]></title><link>https://www.benthamscience.comchapter/20147</link><description><![CDATA[Cancer prevalence across the globe has increased substantially in the last two decades despite significant progress in inpatient care. Cancer, a multifactorial disease, evolved several theories to establish pathophysiological conditions. Uncontrolled proliferation, dedifferentiation and metastasis mainly describe the cancer progression, which must be characterized by cellular and molecular changes. Understanding these processes helps devise the strategy for effectively delivering the drugs to the target sites. The present review described the essential features of cancer pathophysiology and challenges to achieving drug concentration in the targeted area.<br>]]></description> </item><item><title><![CDATA[Animal Models used in Cancer Research: Role of Transgenic Animals]]></title><link>https://www.benthamscience.comchapter/20138</link><description><![CDATA[In spite of the existence of many chronic diseases, cancer is still one of the major distresses for public health and is also the second largest major concern of death. The data collected from the last 50 years of research showed that very few cancers are curable, and the fear factor related to this disease is still unaltered. Victorious bench-tobedside transformation of basic methodical findings about cancer into therapeutic involvements for patients relies on the appropriate selection of animal experimental models. Animal models play an important role in studying the genetics and biology of human cancers as well as the preclinical examination of various cancer therapeutics and cancer prevention. In this chapter, we will review the imperative animal models such as spontaneous tumour models, chemically induced tumour models, radiationinduced tumour models, etc., along with other animal models, such as porcine, canines, etc., used for immuno-oncological research. In addition, the role of transgenic animals in cancer research will also be discussed.<br>]]></description> </item><item><title><![CDATA[Biomarkers for the Diagnosis and Surveillance of Cancer]]></title><link>https://www.benthamscience.comchapter/20137</link><description><![CDATA[Cancer remains one of the leading causes of death worldwide. Cancer management has been a daunting task for both health professionals and patients throughout the journey. Screening of cancer at the right time/stage remains the most critical part of the riddle. Certain molecules that characterize cancer, known as ‘biomarkers,’ come out to be the most useful in this journey. The National Institute of Health defines a biomarker as “a characteristic used to measure and evaluate objectively normal biological processes, pathogenic processes, or pharmacological responses to a therapeutic intervention”. These have proven to be often easily available agents employing minimally invasive methods. Biomarkers have played crucial roles in screening, asymptomatic and early-stage detection, monitoring of the treatment therapy and eventual follow-up to check upon a probable re-lapse or metastasis. A cancer biomarker can be any of the biomolecules such as protein, DNA, RNA, proteoglycans, immunological compounds, salivary biomarkers and endogenous peptides. With the refinement in high-throughput techniques, the list of the types of biomolecules and the number of potential biomarkers is only increasing, with volatile organic compounds from the breath (breath biopsy) adding to the list. In this chapter, we shall put effort into reviewing this otherwise very vast topic. The chapter will outline various types of biomarkers, the journey so far with clinically approved cancer biomarkers, the challenges being faced, and conclude with future perspectives.<br>]]></description> </item><item><title><![CDATA[Biomarkers as Tools for the Early Detection of Cancer]]></title><link>https://www.benthamscience.comchapter/20136</link><description><![CDATA[Every year, millions of people around the world lose their lives to different types of cancer, mostly in developing countries. The foremost challenge for the human race in to fight against cancer is its early detection, followed by the appropriate treatment. Currently, one of the most promising and dynamic strategies for early cancer diagnostics as well as for therapeutics, is the use of cancer biomarkers. Generally, biomarkers represent changes in the constituents or composition of cells, tissues, or body fluids, offering a means for comparable classification of diseases as well as the risk factor involved, and thereby providing information about the underlying pathogenesis of the disease. Similarly, a cancer biomarker (CB) is defined as a ‘molecular signature’ that can potentially provide valid information regarding staging as well as the mechanisms underlying the origin of cancer. Cancer biomarkers (CB) are biomolecules synthesized either by the cancer cells or by other cells of the body in response to cancer. Every cell type has its distinctive molecular signature and recognizable features, such as levels or activities of the myriad of genes, proteins, or other molecular characteristics; therefore, cancer biomarkers can facilitate the molecular definition of cancer. Endoscopy, X-rays, magnetic resonance imaging, computed tomography, invasive tissue biopsies, etc., are the traditional cancer diagnostic methods. However, the use of biomarkers as cancer screening tools have several advantages over these traditional approaches. The emergence of “omics” technologies, like metabolomics, genomics, epigenomics, proteomics, etc., has led to an increase in the number of potentially investigated biomarkers, such as DNA, RNA, miRNA, or other protein biomolecules. In this chapter, we have summarized the importance of biomarkers as powerful and dynamic tools for the early diagnosis of various types of cancers, the phases in the biomarker discovery, the criteria for the selection of biomarkers, the advantages of their preference over traditional methods, various categories of cancer biomarkers, examples of cancer biomarkers currently in use and the future prospectives.<br>]]></description> </item><item><title><![CDATA[Potential of Biomaterials Derived from Marine Algae as Anticancer Agent]]></title><link>https://www.benthamscience.comchapter/20135</link><description><![CDATA[Cancer is one of the most serious and common human diseases, causing millions of deaths per year worldwide. Currently, the discovery of noble therapeutic agents with a natural origin for cancer treatment is a major challenge. In this context, marine algae with wide species and phytochemical diversity will offer great scope for the discovery of new drugs. Algae with marine origin, including microalgae and macroalgae (seaweeds), constitute more than 90% of oceanic biomass. Marine algae are rich sources of pigments, lipids, carotenoids, omega-3 fatty acids, polysaccharides, vitamins and other fine chemicals. The biomaterials obtained from marine algae are important ingredients in many products, including cosmetics and drugs for treating cancer and other diseases. The in vitro and in vivo evaluations of biomolecules derived from marine algae have shown a vast range of pharmacological properties such as antioxidant, immunostimulatory and antitumor activities to control cancer. In spite of the rich source of various bioactive molecules, the marine algal flora largely remains unexplored for the discovery of active molecules against cancer to date. Hence, this review consolidates the available information on marine algae-derived anticancer molecules to provide baseline information for promoting anticancer research based on biomaterials derived from marine algae.<br>]]></description> </item><item><title><![CDATA[Molecular Mechanisms of Flavonoids Mediated Therapy and Chemoprevention of Cancer]]></title><link>https://www.benthamscience.comchapter/20132</link><description><![CDATA[Flavonoids derived from daily dietary source and plant products play a crucial role in the prevention and treatment of various degenerative diseases and cancer. Flavonoids are further subdivided into subclasses such as flavones, flavan-3- ols, flavonols, flavanones, isoflavones and anthocyanidins. There has been a resurgence in the research on flavonoids due to enhancement in the evidence that proves the health benefits of flavonoids. Several preclinical and epidemiological studies revealed that dietary intake of flavonoids may be found helpful in the reduction of risk of tumors like colon, breast, lung, pancreas and prostate. It also acts on the reactive oxygen species, and cellular signal transduction pathways associated with cellular proliferation, angiogenesis and apoptosis. Flavonoids are non-toxic in nature, so intensively studied the broad, vast aspect of their efficacy in biological activities that in turn promotes health benefits and also added to its availability in abundance in our daily diets, for instance, fruits, green leaves, tea, red wine and vegetables. Overall, the exciting data obtained so far elicit that dietary flavonoids have been considered a beneficial cancer preventive approach. This chapter unravels the molecular mechanisms involved in potential cancer preventive efficacy accomplished by the novel biological approach of flavonoids.<br>]]></description> </item><item><title><![CDATA[Antioxidants and Oxidative Stress as Foe and Friends in Prevention of Cancer]]></title><link>https://www.benthamscience.comchapter/20130</link><description><![CDATA[Cancer has become a major public health problem and is one of the leading causes of death among humans worldwide. It is characterized by the abnormal proliferation of cells due to failed normal regulatory mechanisms. Oxidative stress plays a crucial role in the pathology of many cancers and is characterized by an imbalance between the production and removal of reactive oxygen species (ROS). Under normal physiological conditions, the intracellular levels of ROS are steadily maintained to prevent cell damage, and detoxification of ROS is facilitated by various non-enzymatic and enzymatic antioxidants. These antioxidants have a widespread application in the prevention of cancer, as many endogenous and exogenous antioxidants can prevent and repair damage caused by disrupted redox status of cells during carcinogenesis. Our body can produce some of the antioxidants, but to obtain the rest of the antioxidants, it relies on external sources, primarily the diet of an individual. Also, there are certain health issues reported with the long-term usage of synthetic antioxidants. Therefore, nowadays, many nutritionists and dieticians suggest consuming food and natural products that are either rich sources of antioxidants or are supplemented with various nature-based antioxidants. This chapter seeks to explain the role of ROS in oncogenesis, understand the dynamics between oxidative damage and the antioxidants, types of antioxidants, natural sources of antioxidants, mode of action of antioxidants and the role of antioxidants in cancer prevention and treatment along with their disputable effects in cancer therapy.<br>]]></description> </item><item><title><![CDATA[Mechanistic Insight into the Chemotherapeutic Potential of Dietary Phytochemicals]]></title><link>https://www.benthamscience.comchapter/20127</link><description><![CDATA[Globally, cancer is the main cause of mortality and morbidity. Unfortunately, existing medical procedures are not adequate due to a lack of appropriate therapy, adverse health effects, chemoresistance and disease recurrence. In recent years, epidemiological findings have illustrated the connection between the consumption of several phytochemical-enriched foods and nutrients, and the lower risk of different types of cancer. Natural compounds named ‘phytochemicals’, commonly found in fruits, vegetables, and whole grains, have shown convincing beneficial biological effects on human well-beings, including curing different types of cancers. Phytochemicals, which are non-nutritive chemicals present in plants, have come up as modulators of essential cellular signaling pathways exerting proven anti-cancer benefits. Dietary phytochemicals have received major interest in chemoprevention as they are thought to be safe for human use. Chemo-preventive agents restrain the growth of cancer either by impeding DNA damage, which contributes to malignancy or by preventing or restricting the division of premalignant cells through DNA damage. Phytochemicals may prevent carcinogenesis by contributing to cell cycle arrest, autophagy and apoptosis. The bioactive compounds have been reported to reverse adverse epigenetic control, including modifying DNA methylation and histone alteration, modulating the expression of miRNA, inhibiting phase I enzymes, and activation of phase II enzymes, scavenging DNA reactive agents, preventing the excessive proliferation of early, preneoplastic lesions, and suppress other properties of the cancer cells. These have all been a part of indirect yet successful and innovative approaches to cancer treatment utilizing phytochemicals.<br>]]></description> </item><item><title><![CDATA[Allium Species: A Remarkable Repertoire of Nutraceuticals with Anti-cancer Properties]]></title><link>https://www.benthamscience.comchapter/20126</link><description><![CDATA[Cancer - the name evokes fear and anxiety. Researchers are working tirelessly to bring hope to countless patients by developing prevention and treatment strategies. One approach is dietary modulation - which is documented to reduce the risk of cancer and increase the benefit of anti-cancer therapy. Allium species are a part of the daily diet in most parts of the world. Important members of this genus - chives, garlic, onions, and shallots add flavour and nutrition to food. These are prized for their organosulphur compounds and flavonoid content which are responsible for their diverse pharmacological activities. Traditional and scientific literature shows that dietary intake of Allium species prevents and aids the treatment of different cancers. In this review, based on an extensive search of available databases, the role of Allium species as nutraceuticals for cancer management was examined to ascertain the truth in the popular claims. Preclinical and clinical investigations show that consumption of the Allium members as a part of the diet and also the functional components (e.g., allicin, diallyl disulphide, diallyl trisulphide, ajoene, S-allyl cysteine, S-allyl mercaptocysteine, tuberoside M, onionin A, fisetin, quercetin, etc.) reduce risk of cancer and have significant antitumor activities. These act by varied mechanisms, including inhibition of gene expression, promotion of apoptosis of cancer cells, antiproliferative activity, and anti-oxidant and anti-inflammatory effects. It is emphasised that standardization of Allium products, their efficacy, dosage, safety profiles and interactions should be ascertained to corroborate their use. This article highlights the importance of Allium species for their prophylactic, therapeutic and immune-boosting ability in cancer management.<br>]]></description> </item><item><title><![CDATA[Classification Tool to Predict the Presence of Colon Cancer Using Histopathology Images]]></title><link>https://www.benthamscience.comchapter/20016</link><description><![CDATA[The proposed model compares the efficiency of CNN and ResNet50 in the field of digital pathology images. Deep learning methods are widely used in all fields of disease detection, diagnosis, segmentation, and classification. CNN is the widely used image classification algorithm. But it may show less accuracy in case of complex structures like pathology images. Residual Networks are a good choice for pathology image classification because the morphology of digital pathology images is very difficult to distinguish. Colon cancer is one of the common cancers, and it is one of the fatal diseases. If early-stage detection has been done using biopsy results, it will decrease the mortality rate. ResNet50 is selected among the variants as its computational complexity is moderate and provides high accuracy in classification as compared to others. The accuracy metric used here is the training and validation accuracy and loss. The training and validation accuracy of ResNet50 is 89.1% and 90.62%, respectively, whereas the training loss and validation loss are 26.7% and 24.33%, respectively. At the same time, for CNN, the accuracy is 84.82% and 78.12% and the loss is 36.51% and 47.33% .<br>]]></description> </item><item><title><![CDATA[Subject Index]]></title><link>https://www.benthamscience.comchapter/19988</link><description><![CDATA[]]></description> </item><item><title><![CDATA[Chromosome X]]></title><link>https://www.benthamscience.comchapter/19986</link><description><![CDATA[X Chromosome is the sex chromosome that is found in many organisms. Both males and females, including mammalians, have X Chromosomes. Females have XX sets of chromosomes, and males have XY sets of chromosomes. X Chromosome aids in identifying the sex of the organism. The Human X chromosome contains approximately 1500 genes. These genes may undergo some genetic alterations and eventually lead to complex diseases. Genetic mutations in some of the genes of the X chromosome are associated with cancer. Some specific mutations are observed in human cancer cells. This chapter specifically relayed on X chromosomal genes that are associated with different types of cancer and gave information on the location of the gene in the X chromosome. Moreover, the function of the specific gene and information regarding how many types of cancers were associated with a particular gene, has also been provided.<br>]]></description> </item><item><title><![CDATA[Chromosome 22]]></title><link>https://www.benthamscience.comchapter/19985</link><description><![CDATA[When the collection of human Chromosome 22 was first suggested in 1999, it became the most extended, non-stop stretch of DNA ever decoded and assembled. Chromosome 22 became the first of the 23 human chromosomes to decode due to its minimal length and affiliation with numerous diseases. Chromosome 22 involves several genes that contribute to cancer genetics in one way or the other. The contribution of chromosome 22 in abnormalities is evident through somatic translocations, germline and somatic, and in certain cases, overexpression of genes. One famous example is the Philadelphia translocation, particularly in chronic myeloid leukemia cells. Various gene contributions about types of cancer such as Acute Myeloid Leukemia, colorectal, lung, breast cancer and many more have been reported in studies related to chromosome 22. This chapter takes a run-through of important targeted studies of a gene that facilitates itself as a part of cancer genetics.<br>]]></description> </item><item><title><![CDATA[Chromosome 21]]></title><link>https://www.benthamscience.comchapter/19984</link><description><![CDATA[The significance of human chromosome 21 is that the trisomy of human chromosome 21 causes Down syndrome in children. There are about 235 protein-coding genes on chromosome 21. Mutations like translocation in human chromosome 21 cause different conditions such as partial monosomy 21, core binding factor acute myeloid leukemia, ring chromosome 21, and other types of cancers such as acute lymphoblastic leukemia. Mutation in the DSCAM gene causes mental retardation and facial deformities in down syndrome. The human chromosome 21 also comprises the APP gene, where the expression of the gene causes Alzheimer's disease. The genes that are involved in causing Down syndrome and Alzheimer's diseases are also involved in cancer. This chapter discusses 63 genes of human chromosome 21 that are involved in different types of cancer.<br>]]></description> </item><item><title><![CDATA[Chromosome 20]]></title><link>https://www.benthamscience.comchapter/19983</link><description><![CDATA[Over the years, many scientists and doctors have been treating the deadly disease of cancer but are not able to find a permanent treatment for this disease. Also, sometimes it becomes very difficult to understand the mechanisms and causes of cancer as it is a very complex disease that involves many biological processes. Due to the redundancy in our biological system, cancer progression becomes very easy, thus making it difficult to cure. To find the root cause of this disease, we should know what genetic alterations are undergoing, which is causing cancer to progress, and know who is participating in these alterations, like proteins, signaling pathways, or genes. Cancer is caused due to various reasons; it can be due to genetics but mostly due to carcinogens, causing mutations in the genes, thereby making them an oncogene. The Proto-oncogenes are those genes that usually assist the growth of tumor cells. The alteration, mutation, or increased copy number of a particular gene may turn into a proto-oncogene which could end up completely activated or turned on. Many Tumor-causing alterations or mutations related to oncogenes are usually acquired and not inherited. These tumor-causing mutations often actuate oncogenes via chromosomal rearrangement, or alterations in the chromosome, which sequestrates one gene after another, thereby permitting the first gene to prompt the alternative. Search which genes are involved in different cancer types would help scientists proceed with new methods for finding a cure for this disease. This article will depict which genes and their location on which chromosomes, specifically on chromosome 20, are related to different types of cancer.<br>]]></description> </item><item><title><![CDATA[Chromosome 19]]></title><link>https://www.benthamscience.comchapter/19982</link><description><![CDATA[Gene is considered discrete coding units that contain the information for individual proteins. These lot of genes were combined and named DNA which is tightly coiled many times over the histone protein to form Chromosomes. Humans have got 23pairs of chromosomes, including the sex chromosome. The current study is about the major genes and their functions that are present in chromosome 19. There are approximately 1500 genes present in this chromosome, and changes in chromosome 19 are identified in many cancers. Dislocation of the chromosome, a mutation in genes that are present in a chromosome (rearrangements, deletions, or duplications) of DNA in the chromosome, epigenetic modification, and lifestyle changes are some of the chromosomal abnormalities that are responsible for cancer-causing. These changes will trigger the growth of normal cells and induce cancer cell proliferation, migration, invasion, angiogenesis, and metastasis. The signaling pathways like PI3K/AKT, JAK/STAT, NF-κB, and TGF-β are responsible for the various cellular functions with the result of autocrine, juxtacrine, intracrine, paracrine, or endocrine. When the dysregulation of these signaling pathways leads to cancer progression and metastasis. Prostate cancer, breast cancer, gastric cancer, pancreatic cancer, colon cancer, gastric cancer, lung cancer, leukemia, and cervical cancer are the major cancers that are caused because of mutation that occurs in chromosome 19.<br>]]></description> </item><item><title><![CDATA[Chromosome 18]]></title><link>https://www.benthamscience.comchapter/19981</link><description><![CDATA[Cancer is an abnormal or unusual growth of cells in the body with invasive and migrating potential. It leads to loss of function, weakens the immune system, and is the second leading cause of death worldwide. This makes it important to eliminate the disease. Genetic predisposition imposes a high relative risk for several kinds of cancer. Inherited genetic mutations are responsible for causing 5 to 10 percent of all cancers. Scientists have investigated mutations in specific genes with more than 50 hereditary cancer syndromes. For this, chromosome 18 was explored for its genes associated with cancer and this study unveiled 30 genes involved in causing cancer. Of these, the genes DCC, EPB41L3, MBD1 PHLPP1, and RBBP8 were the potential tumor suppressors. This chromosome consists of the target genes of the transforming growth factor-beta (TGF-β) signaling pathway. The SMAD family genes (SMAD4, SMAD7, and SMAD2) are encoded by this chromosome, of which SMAD4 acts as a tumor suppressor. SERPINB5 and TCF-4 were the potential oncogenes. The enzyme coded by TYMS was a potential therapeutic target for chemotherapy. Several fusion genes of this chromosome (SS18-SSX2B, SS18-SSX2, and SS18-SSX4) have been identified to cause cancer. Therefore, this chapter provides a summary of the genes in chromosome 18 that are involved in the initiation and proliferation of cancer and provides an insight into the potential biomarkers and therapeutic targets for clinical application to develop a cancer-free world.<br>]]></description> </item><item><title><![CDATA[Chromosome 17]]></title><link>https://www.benthamscience.comchapter/19980</link><description><![CDATA[Cancer is a disease in which the body's cells divide disorderly and are likely to spread to other organs. It has always been one of the world's top causes of death. A growing population, low mortality rate, and lifestyle changes lead to an increase in the number of cancer cases. It can be caused by genetic or environmental factors or a combination of both. The risk of cancer increases with age as the body loses its ability to eliminate the damaged cells. Cancer-causing genes can be inherited or acquired due to exposure to carcinogens. Cancers are inherited when a mutation occurs in the germ cells. The carcinogens can alter the DNA of a normal gene (a proto-oncogene) converting it into a cancerous oncogene. Genes that slow cell division, fix DNA errors, or undergo programmed cell death (apoptosis) are tumor suppressor genes. Tumor suppressor genes that don't function properly can cause cells to develop out of control, leading to cancer. Cancer expresses itself differently in each individual, making it challenging to identify and treat. Studying the types of genetic mutations, as well as the genes, proteins, and signaling pathways involved in cancer formation will help better understand the underlying cause of cancer. Identifying which genes are expressed in various cancer types will enable scientists to develop novel techniques for curing the disease. This chapter will explain how different cancer types are linked to specific genes and their locations on chromosome 17.&nbsp;<br>]]></description> </item><item><title><![CDATA[Chromosome 16]]></title><link>https://www.benthamscience.comchapter/19979</link><description><![CDATA[Cancer is a heterogeneous disorder with invasive and metastatic potential. It is a deadly disorder affecting 1 in 6 people worldwide. Hence, it is important to eliminate the disease. Genetic alterations remain an underlying cause of cancer, and several gene mutations were involved in causing different types of cancer. Recently, researchers have been investigating the role of genetic mutations in causing cancer. For this reason, the genes associated with chromosome 16 were investigated for their role in causing cancer. This study revealed 70 genes associated with cancer. Of which, the cadherin genes (CDH11, CDH13, and CDH1), AXIN-1, ANKRD11, BANP, CYLD, CBFA2T3, IR8, MVP, MT1F, NQO1 and PYCARD was the tumor suppressor, and the gene MSLN is the potential oncogene. CBFB and MYH11 are well-known fusion genes associated with this chromosome. Loss of heterogeneity was noted in the q arm of this chromosome. The chromosome translocations, t (16;16) (16) (p13q22), t (16;21) (21) (p11;q22), t (12;16) (q13; p13; p11), t(16;21) (p11;q22) and t(7;16) (q33; p11) led to the development of acute myeloid leukemia, leukemia, and sarcoma. Several other genes associated with chromosome 16 responsible for cancer initiation and proliferation are summarized in this chapter. A novel insight into the genetic biomarkers and therapeutic targets has been provided to develop potential therapeutic strategies against cancer.&nbsp;<br>]]></description> </item><item><title><![CDATA[Chromosome 15]]></title><link>https://www.benthamscience.comchapter/19978</link><description><![CDATA[The genomic alteration at chromosome 15 has been widely recognized as the utmost significant and prevalent alteration in several cancers, including non-small-cell lung cancer, breast cancer, ovarian cancer, prostate cancer, gastrointestinal cancer, acute lymphoblastic leukemia, colorectal carcinoma, hepatocellular carcinoma, myeloma, pituitary adenomas, etc. Emerging reports suggest that the abnormalities of prime genes in chromosome 15 have drastic effects on tumor development and progression, and can be candidate biomarkers of disease prognosis, disease progression, and response to treatment. The translocations involving chromosome 15 and other chromosomes have been found in tumors, including mucoepidermoid carcinomas, mixed-lineage leukemia, colorectal cancer, pancreatic cancer, sarcoma, lung adenocarcinoma, melanoma, brain cancer, cholangiocarcinoma, spitz tumor, congenital mesoblastic nephroma, papillary thyroid cancer, pontine glioma tumors, and acute promyelocytic leukemia. The tumor suppressor genes such as C15orf65, CSK, CRABP1, DAPK2, FES, GREM1, KNSTRN, NEDD4-1, NTRK3, PML, SPRED1, TPM1, and TCF12 under chromosome 15 play a crucial role by enhancing cellular growth, proliferation, migration, invasion, metastasis, cellular differentiation, and development in various cancer, including colorectal cancer, acute promyelocytic leukemia, myeloid leukemia, breast cancer, thyroid carcinoma, glioblastoma, intrahepatic cholangiocarcinoma, chondrosarcoma, cartilaginous cancer, Squamous cell carcinoma, non- small-cell lung carcinomas, mucosal melanoma, and oral squamous cell carcinoma. Chapter 15 discusses the significance of each important gene under chromosome 15 in mediating oncogenesis. The elevated or attenuated expression levels of these cardinal genes can either act as an oncogene or a tumor suppressor. Thus, shedding light on these genes would be a game changer in the field of cancer genetics and theragnostic.<br>]]></description> </item><item><title><![CDATA[Chromosome 14]]></title><link>https://www.benthamscience.comchapter/19977</link><description><![CDATA[Cancer genetics has focused on several mutational events within a tumor cell for many years. Recently, the study on cancer genetics has been widened by concentrating on the importance of intercellular communication and epigenetic events causing tumor progression and development. The translocation of genetic material betwixt chromosome 14 and other chromosomes may engender the formation of various types of tumors. Recent studies emphasize that these chief translocations between two chromosomes may disrupt the genes crucial for controlling cell growth and cell division. The translocations involving chromosome-14 and other chromosomes have been found in tumors including acute myeloid Leukemia, acute lymphoblastic leukemia, acute bilineal leukemia, follicular lymphoma, small cell lung cancer, non-Hodgkin’s lymphoma, Burkitt lymphoma and multiple myeloma. The tumor suppressor genes, such as ARID4A, ARID4B, BCL11B, BMP4, CCNB1IP1, CEBPE, DICER1, DLK1, ESR2, FOXN3, HIF1A, MAX, MEG3, NDRG2 and TTF-1/NKX2-1 under chromosome 14, play a hypercritical role by enhancing cellular differentiation, migration, proliferation, metastasis, invasion, cellular growth, and development in several tumors, including breast cancer, pancreatic tumor, osteosarcoma, lung cancer, endocrine tumor, T-ALL, cystic nephroma, Hodgkin lymphoma, pleuropulmonary blastomas, Sertoli Leydig ovarian tumors and rhabdomyosarcoma. Chapter 14 meticulously discusses the importance of each predominant gene under chromosome 14 in mediating tumorigenesis. In cancer genetics, these cardinal genes play a crucial role by acting as an oncogene or a tumor suppressor in several cancers. Thus, targeting these tumor-causing genes would provide a breakthrough in cancer biology and oncology when concerned with future perspectives.<br>]]></description> </item><item><title><![CDATA[Chromosome 13]]></title><link>https://www.benthamscience.comchapter/19976</link><description><![CDATA[Chromosome 13 represents around 4 percent of the total cellular DNA with 115 million base pairs. It is home to various tumor suppressors and oncogenes, such as ADP ribosylation factors like GTPase-11 (ARL11), Retinoblastoma-1 (RB1), Ras-related protein Rap-2a (RAP2A), etc. Most of the somatic mutations in this chromosome lead to cancer development. Further, deletion in this chromosome has been reported to support the cancer of leukemias, lymphomas, etc. In this chapter, we have tried to list cancer-causing genes and their possible oncogenesis in cancer development.<br>]]></description> </item><item><title><![CDATA[Herbs for Cancer]]></title><link>https://www.benthamscience.comchapter/19888</link><description><![CDATA[&nbsp;In the present era of modernization, the new generation differs from the lifestyle maintained in the ancient period. A few decades ago, it was a regular practice of major community, i.e., Early to bed and early to rise, where the body’s clock and nature's clock were more or less similar. During this period of modernization, there was a tremendous change in lifestyle, including daily activities. This results in an early facing of severe problems. Modern medicines very well deal with such issues, but long-term regular use of such medication can affect vital organs in the future. Medicinal herbs have been used worldwide as supportive treatment to minimize the toxic effects of chemotherapy and radiotherapy. Many clinical studies have reported the beneficial results of herbs in combination with conventional therapeutics on the patients' survival, immune modulation, and quality of life. One such disease is cancer, wherein medicines have various side effects and immunity suppression effects. The present chapter deals with different herbs, their role in cancer treatment, and the side effects of their treatment. Here in this chapter, herbs are briefly reviewed that are used for treating various cancers. Different research work and clinical studies are mentioned here that showed the anticancer activities and their effect on various biological pathways. The use of a dietary regime along with medicinal herbs for better results is also a part of Ayurveda to be followed. The state of balance between doshas and dhatus is essential while using herbs in all aspects. This review may help to provide the utility of various herbs in various aspects of cancer and its treatment.<br>]]></description> </item><item><title><![CDATA[Sterols, Carotenoid and Polyprenols]]></title><link>https://www.benthamscience.comchapter/19857</link><description><![CDATA[Isoprenoid compounds are a family of compounds constructed with isoprene as the basic unit but with very different structures, including monoterpenes, diterpenes and polyterpenes. Isoprenoid compounds mainly include ergosterol, steroids, carotene, carotenoids, polyisoprene, and their structures range from relatively simple linear hydrocarbon chains to highly complex cyclic structures, in which the cyclic structure is cyclized by terpenoids. Enzymes, also known as terpene synthase catalyzed by them, are also called cyclic terpenes. Isoprenoids are widely distributed in archaea, bacteria, and eukaryotes, and a variety of isoprenoids are essential components of the biological mechanism of the organism. For example, in mammals, β-carotene (β-carotene) is the precursor substance of Vitamin A. β-carotene has the function of preventing oxidation reactions, and can inhibit and eliminate oxygen free radicals in the body, and has various effects such as slowing down aging and improving resistance. At the same time, carotenoids can be combined with protein. Astaxanthin and protein combine to form astaxanthin, which makes aquatic animals appear body color and has a certain protective effect. Therefore, ergosterol, steroids, carotene, carotenoids and polyisoprene, which are relatively large in terpenoids, are all important products with commercial value and have been widely used in food, medicine, and daily chemical products.<br>]]></description> </item><item><title><![CDATA[Exploring the Traditional System of Medicine With Special Emphasis on the Indigenous Practice of Herbal Remedy by the Tribals of North-East India]]></title><link>https://www.benthamscience.comchapter/19816</link><description><![CDATA[The tribal people of India consider North-East India to be a hotspot. It contains eight states: Arunachal Pradesh, Assam, Manipur, Mizoram, Meghalaya, Nagaland, Tripura and Sikkim, and it borders international boundaries with Bhutan, Tibet, China, Burma and Bangladesh. The Indo-Burma biodiversity hotspot, which is home to a broad spectrum of unusual flora, fauna and microorganisms, is located in the Northeast Region. The region has the evergreen forest of the Brahmaputra River valley, wide leaf forest, dense bamboo and pine forest and the world's wettest location (Cherrapunji and Mawsynram), all of which help to maintain the region's unique biodiversity. North East region is the inhabitant of more than 145 significant tribal communities with the most dominating primitive societies, including the Abor, Mishing, Rabha, Khasi, Kuki, Naga, Meitei, Apatani, etc. Most of these communities are culturally and linguistically diverse. The NER's tribal population is literate compared to other parts of the country, and it's worth noting that the literacy rates in Mizoram, Meghalaya, Nagaland, Sikkim and Manipur are all higher than the national average. Despite their high literacy rate, India's North-Eastern states continue to have poor transportation, power and medical services. The healthcare system is in bad shape, with only a few hospitals and nursing homes. As a result, the people residing in this area rely exclusively on a traditional system of medicines made by traditional healers from plants, animals and mineral resources. It was stated that medicinal herbs are prepared using traditional methods, such as maceration, decoction, and infusion, either alone or in combination with other plants. The key species of medicinal plants often employed by the traditional healers of the region are Acorus calamus, Aegle marmelos, Asparagus racemosus, Averrhoa carambola, Bryophyllum calycinum, Costus speciosus, Euphorbia neriifolia, Justicia adhatoda, Melia azadarachta, Plumeria acutifolia, Sida cordifolia, Sida rhombifolia and Swertia chirata. This extensive work will aid the researcher in locating previously unknown medicinal plants in order to build a new therapeutic method for isolating new chemical entities that are safe, pharmacologically active, and cost-effective.&nbsp;<br>]]></description> </item><item><title><![CDATA[Subject Index]]></title><link>https://www.benthamscience.comchapter/19789</link><description><![CDATA[]]></description> </item><item><title><![CDATA[Destructive Effects of Steroidal Drug Abuse and their Immunological Impact]]></title><link>https://www.benthamscience.comchapter/19788</link><description><![CDATA[Steroidal drugs are synthetic in nature that are closely identical to naturally produced hormones in our body such as cortisol and testosterone. They are lifesavers for several threatening medical conditions. They are currently in wide use for the treatment of various inflammatory diseases since they are known to involve in suppressing the immune system resulting in a reduced inflammatory process. They are produced in different forms and do not cause any major side effects when consumed at low doses. However, occasionally they lead to perilous side effects when taken in appropriate doses that lead to mental health problems, high blood pressure, diabetes, osteoporosis, etc. Practices such as the uptake of illicit anabolic steroids and corticosteroid drugs without an appropriate prescription can potentially lead to fatal side effects. Anabolic steroids are performance and image-enhancing drugs that were once viewed as predicament associated with bodybuilders and have now become a widespread problem throughout our society including children. Dietary supplements which act as steroidal precursors also promote medical consequences that are similar to steroids and the absence of such awareness in our society leads to varied difficulties in our current lifestyle. The increasing concern about possible health hazards in association with abusive steroid drug uptake should be addressed with strict measures. It is important to educate our society about the hazardous effects of steroidal drug abuse and the precautions that need to be carried out while using them. This chapter highlights different types of steroid drugs that are currently in use and the deleterious side effects caused by their abusive use. Potential treatments for their withdrawal and preventive measures will also be addressed in detail.<u></u>&nbsp;<br>]]></description> </item><item><title><![CDATA[Plant Cardenolides: Multifunctional Medicinal Agents]]></title><link>https://www.benthamscience.comchapter/19784</link><description><![CDATA[Cardenolides are a class of compounds steroidal in nature, belonging to the cardiac glycoside group of secondary metabolites. They consist of a sugar part and a non-sugar part consisting of a steroidal cyclopentanoperhydrophenanthrene ring with lactone substitution at the β-17 position. Cardenolides are found in angiosperm plant families like Plantiginaceae, Asclepiadaceae, Apocynaceae, Brassicaceae, Cruciferae, Liliaceae, Moraceae, Ranunculaceae, and Scrophulariaceae. These include some important glycosides, such as digitoxin, digoxin, Ouabain, Calotropin, etc. with profound pharmacological potential. Moreover, cardenolides have toxic effects for which these have been used in poison arrows and for self-harm purposes. Traditionally, these were used to treat congestive heart failure. However, recently they have emerged as promising agents to exhibit anticancer, antiviral, anti-inflammatory, neuroprotective, and various other therapeutic roles. Cardenolides like Digoxin and Digitoxin have been used in the treatment of heart failure and atrial fibrillation. Toxicarioside A, and Calotropin have been reported to suppress tumor growth and are used as anticancer agents, Strophalloside and Oubain are reported to be involved in apoptosis. Oleandrin is an antiproliferative agent and can inhibit IL-8 which is responsible for cystic fibrosis.<br>]]></description> </item><item><title><![CDATA[Biological Significance of Steroids]]></title><link>https://www.benthamscience.comchapter/19782</link><description><![CDATA[Steroids display varied biological functions and play a crucial role in the fascinating fields of biology, chemistry, and medicine.Steroids encompass wideranging natural products which are abundantly encountered in eukaryotic organisms. These exhibit a pivotal role in regulating the cellular functions of animals, plants, and fungi. Furthermore, they act as chemical messengers in the human body and get secreted in the systemic circulation and extracellular fluids, where they regulate metabolic, immune, and reproductive functions. Steroids are the fundamental components of cell membranes and serve primarily as signalling molecules. This chapter gives a comprehensive overview of physiologically active steroids in various organisms.The biological activities of various steroid classes have been discussed in detail. Glucocorticoids are a class of steroid hormones that regulate the metabolic processes involving the formation of glucose from amino acids and fatty acid deposition of glycogen in the liver. Another important group of hormones, called mineralocorticoids, helps in balancing water and electrolyte content in the body and primarily affects the kidney. The principal class of steroids viz. the sex hormones are essentially crucial for the development and maintenance of reproductive function and cause stimulation of secondary sexual characteristics in humans. To summarize, steroids stabilize and regulate the structure and functions of cellular membranes and play a crucial role in regulating growth and development.&nbsp;<br>]]></description> </item><item><title><![CDATA[Subject Index]]></title><link>https://www.benthamscience.comchapter/19763</link><description><![CDATA[]]></description> </item><item><title><![CDATA[Biosynthesis of Nanomaterials via Plant Extracts]]></title><link>https://www.benthamscience.comchapter/19746</link><description><![CDATA[Nanoparticles (NPs) have become a hot research material in many fields, such as catalysis, sensing, clinical diagnosis, medical treatment, antimicrobial agents, and environmental remediation, due to their small size, high surface area, high reactivity, and unique optical, electrical, and thermodynamic properties. The type, morphology, size, and surface function modification of NPs determine their performance and application scope. The development of green, simple, and controllable NP synthesis methods is an important research direction at present. The biosynthesis of NPs is a kind of green synthesis method that uses organisms or biomolecules to reduce NP precursors. The reaction conditions are mild, the energy consumption is low, and there is no need for expensive equipment or harmful chemicals. It has been developed into an important branch of nanobiotic technology. This chapter summarizes the latest progress in the synthesis of NPs from different plant tissue extracts. It also summarizes the biosynthesis mechanism and application of NPs, analyzes the main problems faced by the biosynthesis method, and prospects its future research direction.<br>]]></description> </item><item><title><![CDATA[Chromosome 12]]></title><link>https://www.benthamscience.comchapter/19711</link><description><![CDATA[Chromosome 12 spans about 134 million DNA building blocks and represents approximately 4.5 percent of the total cellular DNA. Gene dysregulation from chromosome 12 has triggered a cell to transform into a cancerous cell. Different types of genes are present in chromosome 12 that cause colon cancer, ovarian cancer, prostate cancer, ampulla of Vater cancer (Vater cancer), etc. These genes play their role in the development and the progression of cancer into metastasis, Epithelial to mesenchymal transition, and overall cancer growth. In this chapter, we have enlisted the genes responsible for cancer and their short introduction.<br>]]></description> </item><item><title><![CDATA[Chromosome 11]]></title><link>https://www.benthamscience.comchapter/19710</link><description><![CDATA[Over the years, many scientists and doctors have been treating the deadly cancer disease but cannot find a permanent treatment for this disease. Also, sometimes it becomes tough to understand the mechanisms and causes of cancer as it is a very complex disease that involves many biological processes. Due to the redundancy in our biological system, cancer progression becomes very easy, thus making it difficult to cure. To find the root cause of this disease, we should know what genetic alterations are causing cancer progress and who is participating in these alterations, like proteins, signaling pathways, or genes. Cancer is caused due to various reasons; it can be due to genetics but primarily due to carcinogens, causing mutations in the genes, thereby making them an oncogene. The Proto-oncogenes are those genes that usually assist the growth of tumor cells. The alteration, mutation, or increased copy number of a particular gene may turn into a proto-oncogene, which could end up completely activated or turned on. Many Tumor-causing alterations or mutations related to oncogenes are usually acquired and not inherited. These tumor-causing mutations often actuate oncogenes via chromosomal rearrangement or changes in the chromosome, which sequestrates one gene after another, thereby permitting the first gene to prompt the alternative. Search which genes are involved in different cancer types would help scientists proceed with new methods for finding a cure for this disease. This article will depict which genes and their location on which chromosomes, specifically on chromosome 11, are related to different types of cancer.<br>]]></description> </item><item><title><![CDATA[Chromosome 10]]></title><link>https://www.benthamscience.comchapter/19709</link><description><![CDATA[Chromosome 10 contains various genes that are significantly involved in tumorigenesis. These genes described herein that play roles in cancer comprise receptor tyrosine kinases (FGFR2), proto-oncogenes (FRAT1, RET), tumor suppressor genes (PTEN, KLF6), and also genes involved in signal transduction (MAPK8), gene fusions (CCDC6, KIF5B, VTI1A), developmental processes (GATA3, NODAL), Epithelial- Mesenchymal transition (ZEB1, VIM) and epigenetic regulation (MLLT10). This chapter provides a compilation of many such genes from Chromosome 10 that are associated with cancer, with vivid delineations of the underlying molecular mechanisms of each gene in its contribution to cancer initiation, progression and metastasis. Genes that are insufficiently investigated but implicated in tumorigenesis have also been described in this chapter.<br>]]></description> </item><item><title><![CDATA[Chromosome 9]]></title><link>https://www.benthamscience.comchapter/19708</link><description><![CDATA[Chromosome 9 represents approximately 4.5 percent of the total DNA in cells, and it’s a submetacentric type of chromosome. Chromosomal abnormalities in chromosome 9 have been reported in different kinds of cancer, for example, deletion of the long-q arm, a fusion of ABL1 with BCR results in the ABL1-BCR fusion gene, etc. Bladder cancer, chronic myeloid leukemia, etc., are several cancer types resulting from genetic changes in the genes present in chromosome 9. Dysregulation of the tumor suppressor genes or activation of the oncogene from chromosome 9 has supported the normal cell’s transformation. Here, we have listed a few top genes reappearing themselves as causative agent for cancer development in cancer and types of cancer.<br>]]></description> </item><item><title><![CDATA[Chromosome 8]]></title><link>https://www.benthamscience.comchapter/19707</link><description><![CDATA[Chromosome 8 spans more than 146 million DNA base pairs, and represents between 4.5 and 5 percent of the total DNA in cells. Sixteen percent of these genes and their mutations have been identified to play a role in cancer development. Cancer is a genetic disease at the somatic cell level. Multiple gene mutations usually precede them throughout one’s life. Oncogenes such as Myc, Lyn, Atad2, etc., from chromosome 8 promoted cancer cell proliferation, invasion, and migration. The increased expression of these proteins can transform a normal cell into a cancer cell. Chromosome 8 also houses multiple tumor suppressor genes, such as Dlc1, E2f5, Gata4, Ido1, etc. These proteins, when expressed, reduce the chances of tumor initiation within cells. Thus, mutations leading to the reduced expression of these genes are associated with multiple cancers. Mutation of other functional genes like Ank1, Ctsb, Ext1, Il7, etc., has also been implicated in various cancers for their role in increasing the invasive nature of cancers by regulating angiogenesis and facilitating cancer metastasis. Cancers can also stem from the translocational mutations of genes in chromosome 8. This chapter explains essential cancer genes, genetic mutations, and gene variations that can cause an increased risk of cancer and its progression.<br>]]></description> </item><item><title><![CDATA[Chromosome 7]]></title><link>https://www.benthamscience.comchapter/19706</link><description><![CDATA[Chromosome 7 consists of 159 million base pairs, and around 950 genes, representing at least 5 percent of the entire DNA in a cell. Various genes that regulate cell division and cellular growth are present in Chromosome 7. Aberrations in these genes can therefore lead to tumorigenesis. Lymphomas and Leukemia have been frequently correlated with abnormalities on chromosome 7. Aberrations in chromosome 7, such as aneusomy in prostate cancer, gene amplifications in gastric cancer, and chromosomal gain in glioblastoma, are some of the starkly real ramifications of genetic abnormalities on chromosome 7. Numerous essential genes from Chromosome 7, including ABCB5, BRAF, CDK6, EGFR, ETV1, EZH2, IL6, and TWIST1, involved in cancer have been explained in this chapter.<br>]]></description> </item><item><title><![CDATA[Chromosome 6]]></title><link>https://www.benthamscience.comchapter/19705</link><description><![CDATA[Chromosome 6 is among the 23 pairs of chromosomes in humans and it spans about 170 million base pairs. Several cancer genes have been identified to have a role in cancer development. Cancer is also a genetic disease caused due to changes in the genes that control cell function, such as cell division and cell growth. Most of these cancer genes either act as tumor suppressors or possess an oncogenic potential. Oncogenes like ROS1, MYB, HMGA1, etc., induce tumorigenesis by playing a role in DNA repair, replication, transcriptional regulation, and mRNA splicing. When these genes are highly expressed, they result in the transformation of normal cells to malignant cells; on the other side, tumor suppressor genes like IGF2R, AIM1, IRF4, etc., reduce tumorigenicity and invasive potential. Thus, reduced expression of these genes due to loss of heterozygosity, deletion or any epigenetic modifications can induce tumor formation. Also, some genes can either suppress or induce tumor formation given the cellular location and condition, such as CCN2, TNF, etc. Along with these, different types of structural abnormalities can be observed on chromosome 6, such as chromosomal translocation, deletion, duplication, and inversion. These abnormalities on both p and q arms have been known to contribute to the growth and spread of cancer by impacting the expression of cancer genes. Aberrant expression of the genes can also be influenced by fusions, missense mutations, non-missense mutations, silent mutations, frame-shift deletions, and insertion at the molecular level. Some genes can maintain stem-cell-like properties by regulating the expression of cell surface markers like Oct4, Nanog, Sox4, etc. This chapter explains important cancer genes, genetic mutations, and gene variations that can influence the risk of having cancer and induces cancer formation.<br>]]></description> </item><item><title><![CDATA[Chromosome 5]]></title><link>https://www.benthamscience.comchapter/19704</link><description><![CDATA[Chromosome 5 presents an extensive collection of genes, and includes several cancer-associated ones. The contribution of chromosome 5 in abnormalities is evident through somatic translocations, germline, somatic, and, in some instances, expression of genes. Various syndromes are associated with chromosome 5, such as 5q minus syndrome, leading to the development of acute myeloid leukemia, PDGFRBassociated chronic eosinophilic leukemia contributing to acute myeloid leukemia, and myelodysplastic syndromes. Studies propose that a few genes on chromosome 5 play important roles withinside the increase and department of cells. When chromosome segments are deleted, as in a few instances of AML and MDS, those crucial genes are missing. Without those genes, cells can develop and divide too speedy and in an out-o- -control way. Researchers are trying to perceive the genes on chromosome five that might be associated with AML and MDS.<br>]]></description> </item><item><title><![CDATA[Chromosome 4]]></title><link>https://www.benthamscience.comchapter/19703</link><description><![CDATA[Chromosome 4 represents around 6 percent of the total DNA in the cell with 191 million DNA base pairs. Genetic changes in chromosome 4, such as somatic mutation, and chromosomal rearrangement like translocation, gene deletion, etc., have been reported to develop several types of cancer. This includes leukemias, multiple myeloma, oesophageal squamous cell carcinoma, prostate cancer, breast cancer, bladder cancer, etc. In this chapter, we have listed genes residing in chromosome 4, which further frequently support cancer development, progression, and metastasis.<br>]]></description> </item><item><title><![CDATA[Chromosome 3]]></title><link>https://www.benthamscience.comchapter/19702</link><description><![CDATA[Myriad genes in the genome have been implicated in cancer. However, a focused compilation of genes from the same chromosome would provide a valuable detailed yet succinct catalog for researchers, advantageous in quickly understanding the leading roles played by these genes in cancer. This chapter fulfills the above aim of furnishing a pocket dictionary- like a concise yet meticulous explanation of many genes from Chromosome 3, describing these genes’ functional essentialities in various cancers. Such a judicious collection of genes from a single chromosome is probably the first of its kind. The multiple inputs in this chapter from Chromosome 3 include oncogenes (BCL6, RAF1), tumor suppressor genes (SRGAP3, FHIT), transcription factors (FOXP1, MITF), fusion genes (MECOM), and many other types. With approximately 1085 genes spanning 198 million base pairs, Chromosome 3 constitutes 6.5% of the total DNA.<br>]]></description> </item><item><title><![CDATA[Chromosome 2]]></title><link>https://www.benthamscience.comchapter/19701</link><description><![CDATA[The human chromosome 2 was formed by a head-to-head fusion mutation caused by two chromosomes of our ancestors. The gorilla and chimpanzee contain 48 chromosomes in contrast to 46 chromosomes in humans. Ten million years ago, the two chromosomes of apes underwent telomere-to-telomere fusion that gave rise to human chromosome 2. Apart from the exciting history, the human chromosome 2 is involved in various genetic conditions caused due to chromosomal deletions and duplications, leading to SATB2 (Special AT-rich sequence-binding protein 2)-associated syndrome, MBD5 (Methyl-CpG-binding domain 5)-associated neurodevelopmental disorder, 2q37 deletion syndrome, partial trisomy 2, myelodysplastic syndrome as well as cancer. These mutations cause different human abnormalities, such as craniofacial anomalies, cleft palate, genitourinary tract anomalies, microcephaly, hypotonia, heart defects, anemia, and myeloid malignancies. This chapter discusses 50 genes of human chromosome 2 involved in various cancer types.<br>]]></description> </item><item><title><![CDATA[Chromosome 1]]></title><link>https://www.benthamscience.comchapter/19700</link><description><![CDATA[Chromosome 1 is the largest human chromosome, constituting approximately 249 million base pairs. Chromosome 1 is the largest metacentric chromosome, with “p” and “q” arms of the chromosome almost similar in length. Chromosome 1 abnormalities or inclusion of any mutations leads to developmental defects, mental, psychological, cancer, etc., among the most common diseases. 1/10th of the genes in chromosome 1 have been reported its involvement in cancer growth and development. These cancer genes result from chromosomal rearrangement, fusion genes, somatic mutations, point mutation, gene insertion, gene deletion, and many more. Some of these cancer-causing genes appear to be involved in cancer more often, and other novel genes are also enlisted in this chapter.<br>]]></description> </item><item><title><![CDATA[Subject Index]]></title><link>https://www.benthamscience.comchapter/19594</link><description><![CDATA[]]></description> </item></channel></rss>